0001121781-13-000366.txt : 20130924 0001121781-13-000366.hdr.sgml : 20130924 20130924172529 ACCESSION NUMBER: 0001121781-13-000366 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20130430 FILED AS OF DATE: 20130924 DATE AS OF CHANGE: 20130924 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDCAREERS GROUP, Inc. CENTRAL INDEX KEY: 0001438901 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 261580812 STATE OF INCORPORATION: NV FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-152444 FILM NUMBER: 131112865 BUSINESS ADDRESS: STREET 1: 758 E. BETHEL SCHOOL RD. CITY: COPPELL STATE: TX ZIP: 75019 BUSINESS PHONE: 9723935892 MAIL ADDRESS: STREET 1: 758 E. BETHEL SCHOOL RD. CITY: COPPELL STATE: TX ZIP: 75019 FORMER COMPANY: FORMER CONFORMED NAME: Rx Scripted, Inc. DATE OF NAME CHANGE: 20080630 10-Q 1 mcgi10q43013.htm

United States

Securities and Exchange Commission

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 30, 2013

[ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934

From the transition period ___________ to ____________.

Commission File Number 333-152444

MEDCAREERS GROUP, INC.

(Exact name of small business issuer as specified in its charter)

Nevada

7389

26-1580812

(State or jurisdiction of incorporation or organization)

(Primary Standard Industrial

Classification Code Number)

(IRS Employer

Identification No.)

758 E Bethel School Road, Coppell, Texas 75019

(Address of principal executive offices)

(972) 393-5892

(Issuer's telephone number)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:

Yes [ ] No [X ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer [ ] Accelerated Filer [ ]

Non-Accelerated Filer [ ] Smaller Reporting Company [X]

Indicate by a check mark whether the company is a shell company (as defined by Rule 12b-2 of the Exchange Act:

Yes [ ] No [X ].

As of September 5, 2013, there were 52,708,863 shares of Common Stock of the issuer outstanding.

TABLE OF CONTENTS


PART I.	FINANCIAL STATEMENTS

ITEM 1.	Financial Statements	3
	Notes to Financial Statements	7

ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	12
ITEM 3.	Quantitative and Qualitative Disclosure About Market Risk	17

ITEM 4.	Controls and Procedures	17


PART II.	OTHER INFORMATION

ITEM 1.	Legal Proceedings	18

ITEM 1A.	Risk Factors	18

ITEM 2.	Unregistered Sales of Securities and Use of Proceeds	18

ITEM 3.	Default Upon Senior Securities	20

ITEM 4.	Mine Safety Disclosures	20

ITEM 5.	Other Information	20

ITEM 6.	Exhibits	20

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Balance Sheets

As of April 30, 2013 and January 31, 2013

(Unaudited)

	As of April 30, 2013			As of January 31, 2013
Assets
Current Assets
Cash and Cash Equivalents	$	30,718		$	89,680
Other Current Assets		1,385			0
Total Current Assets		32,103			89,680
Property, Plant & Equipment
Equipment		1,799			1,799
Less: Accumulated Amortization		(1,799	)		(1,799	)
Total Fixed Assets		0			0

Other Assets
Deferred Fees (net)		50,280			92,217

Total Assets	$	82,383		$	181,897

Liabilities and Stockholders’ Equity
Current Liabilities
Accounts Payable	$	10,625		$	6,918
Accrued Expenses		2,838			11,852
Due to Related Parties		215,424			178,143
Accrued Interest Payable		106,630			89,333
Current Portion of Notes Payable		640,650			578,150
Total Current Liabilities		976,167			864,396

Long Term Liabilities
Notes Payable		640,650			603,150
Less: Current Portion		(640,650	)		(578,150	)
Total Long Term Liabilities		0			25,000

Total Liabilities		976,167			889,396

Stockholders’ Equity
Preferred Stock, $0.001 par value, 10,000,000 shares, none outstanding		0			0
Common Stock, $0.001 par value, 350,000,000 shares,
50,125,528 and 50,125,528 shares issued and outstanding		50,126			50,126

Additional Paid In Capital		3,997,996			3,997,996
Accumulated (Deficit)		(4,941,906	)		(4,755,621	)
Total Stockholders’ Equity (Deficit)		(893,784	)		(707,499	)

Total Liabilities and Stockholders’ Equity	$	82,383		$	181,897

The Accompanying Notes are an Integral Part of these Financial Statements.

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Statement of Operations

For the Three Months Ended April 30, 2013 and 2012

And Cumulative Since Re-Entering the Development Stage, January 1, 2009 to April 30, 2013

(Unaudited)

	Three Months Ended
	April 30, 2013			April 30, 2012			Cumulative Since Re-Entering the Development Stage, Jan 1, 2009

Revenue	$	5,735		$	2,045		$	46,899
Cost of Sales		16,133			4,964			126,847
Gross Profit (Loss)		(10,398	)		(2,919	)		(79,948	)

Operating Expenses:
Depreciation and Amortization		41,937			33,000			589,717
Selling and Advertising Expenses		12,608			1,774			97,029
General and Administrative		102,545			67,082			2,917,470
Total Operating Expenses		157,090			101,856			3,604,216

Net Operating (Loss)		(167,488	)		(104,775	)		(3,684,164	)

Other Income (Expense)
Loss on Sale of Assets		0			0			(4,087	)
Loss on Recapitalization		0			0			(223,454	)
Interest Expense		(18,797	)		(16,149	)		(357,299	)
Total Other Income (Expense)		(18,797	)		(16,149	)		(584,840	)

Net Loss	$	(186,285	)	$	(120,924	)	$	(4,269,004	)

Basic and Diluted Earnings (Loss) per share	$	0.00		$	0.00

Weighted Average Shares Outstanding:
Basic and Diluted		50,125,528			43,350,112

The Accompanying Notes are an Integral Part of these Financial Statements.

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Statement of Changes in Stockholders’ Equity

For the Three Months Ended April 30, 2013 and

For the Year Ended January 31, 2013

(Unaudited)


						Retained
	Common Stock				Paid-In		Earnings
	Shares		Amount		Capital		(Deficit)			Totals

Balance, January 31, 2012	43,315,000	$	43,315	$	2,819,470	$	(3,407,669	)	$	(544,884	)

Issuance of Common Stock for Cash	3,219,500		3,220		318,780					322,000
Issuance of Common Stock for Services	750,000		750		74,250					75,000
Issuance of Common Stock for Deferred Fees	2,840,528		2,841		307,129					309,970

Stock Option Expense					478,367					478,367

Net (Loss)							(1,347,952	)		(1,347,952	)

Balance, January 31, 2013	50,125,028	$	50,126	$	3,997,996	$	(4,755,621	)	$	(707,499	)



Net (Loss)							(186,285	)		(186,285	)

Balance, April 30, 2013	50,125,028	$	50,126	$	3,997,996	$	(4,941,906	)	$	(893,784	)

The Accompanying Notes are an Integral Part of these Consolidated Financial Statements.

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Consolidated Statements of Cash Flows

For the Three Months Ended April 30, 2013 and 2012

And Cumulative Since Re-Entering the Development Stage, January 1, 2009 to April 30, 2013

(Unaudited)

	Three Months Ended April 30, 2013			Three Months Ended April 30, 2012			Cumulative Since Re-Entering the Development Stage, January 1, 2009
CASH FLOWS FROM OPERATING ACTIVITIES

Net Income (Loss)	$	(186,285	)	$	(120,924	)		$	(4,269,004	)

Adjustments to reconcile net deficit to cash used by operating activities:
Depreciation and Amortization of Property and Equipment		0			0				25,826
Amortization of Deferred Fees		41,937			33,000				563,890
Common Stock Issued for Services		0			0				165,000
Stock Option Expense		0			10,347				1,986,017
Change in Assets and Liabilities:
(Increase) in Other Current Assets		(1,385	)		(300	)			(1,365	)
(Increase) in Other Assets		0			0				60,194
Increase (Decrease) in Accounts Payable		3,707			(5,652	)			18,845
Increase in Accrued Expenses		25,614			23,767				117,960
Increase in Due to Related Party		19,950			41,400				198,093
CASH FLOWS (USED IN) OPERATING ACTIVITIES		(96,462	)		(18,362	)			(1,134,564	)

CASH FLOWS FROM INVESTING ACTIVITIES
Sale of Fixed Assets		0			0				191,026
Net Assets Acquired in Acquisition		0			0				(215,453	)
CASH FLOWS (USED IN) INVESTING ACTIVITIES		0			0				(24,427	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Notes Payable		37,500			5,000				615,650
Proceeds from Sale of Common Stock		0			12,500				322,000
Debt Assumed in Acquisition		0			0				246,670
Debt Assumed on Divestiture		0			0				(185,939	)
Interest Added to Notes Payable		0			0				209,429
Payments on Notes Payable		0			0				(35,731)
Common Stock Issued on Recapitalization		0			0				16,000
CASH FLOWS PROVIDED BY FINANCING ACTIVITES		37,500			17,500				1,188,079

NET INCREASE (DECREASE) IN CASH		(58,962	)		(862	)			29,088
Cash, beginning of period		89,680			912				1,630

Cash, end of period	$	30,718		$	50			$	30,718

SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for Interest	$	0			0			$	57,740
Taxes paid	$	0			0			$	0
Issuance of Common Stock for Services	$	0			0			$	165,000
Issuance of Common Stock for Debt	$	0			0			$	884,741
Issuance of Common Stock for Fees	$	0			0			$	614,170

The Accompanying Notes are an Integral Part of these Financial Statements.

MEDCAREERS GROUP, INC.

(A Development Stage Company)

Notes to Financial Statements

April 30, 2013 and January 31, 2013

NOTE 1 – NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Activities, History and Organization – The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada Corporation as RX Scripted, Inc. on December 5, 2007. On December 16, 2009, an amendment was filed with the State of Nevada to change the name to “MedCareers Group, Inc.” (the “Company” or “MedCareers”) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its Common Stock in exchange for 100% of Nurses Lounge, Inc. (“Nurses Lounge”), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly owned subsidiary of MedCareers. As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers. The transaction was regarded as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company. The share exchange was treated as a recapitalization of MedCareers. As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital The Company operates an online professional network for nurses designed to provide a common platform for nursing organizations such as nursing schools, associations and major nurse employers to connect and communicate more effectively to their nurse constituents and broader nursing profession.

Significant Accounting Policies:

The Company’s management selects accounting principles generally accepted in the United States of America and adopts methods for their application. The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements.

The financial statements and notes are representations of the Company’s management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.

Basis of Presentation:

The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States.

Principles of Consolidation:

The financial statements include the accounts of Medcareers Group, Inc. as well as Nurses Lounge, Inc. All significant inter-company transactions have been eliminated. All amounts are presented in U.S. Dollars unless otherwise stated.

Emerging Growth Company Critical Accounting Policy Disclosure:

The Company qualifies as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging grown company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company may elect to take advantage of the benefits of this extended transition period in the future.

Reclassifications:

Certain prior year amounts have been reclassified to conform with the current year presentation. Specifically, additional paid-in capital has been reclassified to show the effect of a forward 10 for 1 stock split effective January 7, 2010.

Cash and Cash Equivalents:

The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents. At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The carrying amount approximates fair market value.

Fixed Assets:

Fixed assets are carried at cost. Depreciation is provided over each asset’s estimated useful life. Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income. Additions and significant improvements are capitalized and depreciated.

Advertising Costs:

The Company incurred $0 advertising costs for the periods ended April 30, 2013 and 2012, respectively.

Income Taxes:

Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code. Although the Company has tax loss carry-forwards (see Note 4), there is uncertainty as to utilization prior to their expiration. Accordingly, the future income tax asset amounts have been fully offset by a valuation allowance.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

Use of Estimates:

In order to prepare financial statement in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determines whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based.

Fair Value of Financial Instruments:

Pursuant to ASC No. 820, “Fair Value Measurements and Disclosures”, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of April 30, 2012. The Company’s financial instruments consist of cash, accounts payable, advances and notes payable. The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.

Stock Split:

On January 4, 2010, MedCareers approved a 10 for 1 forward stock split on its issued and outstanding shares of common stock to the holders of record as of January 7, 2010. The accompanying financial statements and related notes thereto have been adjusted accordingly to reflect this forward stock split retroactively.

Revenue Recognition:

Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned. The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured. For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (“SAB 104”). Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sale price is fixed or determinable and receipt of payment is probable.

Development Stage Company:

The Company complies with Accounting Codification Standard 915-10 for its characterization of the Company as development stage.

Earnings per Common Share:

Earnings (loss) per share are calculated in accordance with ASC 260 “Earnings per Share”. The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share. Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding. Dilutive potential common shares are additional common shares assumed to be exercised. Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive.

There were no potentially dilutive common stock equivalents as of April 30, 2013 and, therefore basic earnings per share equals diluted earnings per share for the periods ended April 30, 2013 and January 31, 2013. The Company had 9,970,500 options outstanding at April 30, 2013. As the Company incurred a net loss during the periods ended April 30, 2013 and January 31, 2013, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive.

Recently Issued Accounting Pronouncements:

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

NOTE 2 – DEFERRED FEES

Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at April 30, 2013 and January 31, 2013 were as follows:

		April 30, 2013				January 31, 2013
Deferred Fees – Net		$	50,280			$	92,217

NOTE 3 - NOTES PAYABLE

The components of the Company’s debt as of April 30, 2013 and January 31, 2013 were as follows:

	2013			2012
Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2013	$	100,000		$	100,000
Note Payable - $190,000, 12% interest payable monthly or accrued, due Oct 29, 2013		310,650			288,150
Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014		25,000			25,000
Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2013		45,000			25,000
Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014		16,000			16,000
Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013		70,000			70,000
Note Payable - $40,000, 12% interest added to note quarterly, due April 28, 2013		40,000			40,000
Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2013		4,000			4,000
Note Payable - $30,000, 12% interest added to note quarterly, due Nov 5, 2013		30,000			30,000
Note Payable - $5,000, 12% interest added to note quarterly, due Nov 5, 2013		5,000			5,000
Subtotal		640,650			603,150
Less – currently payable		(640,650	)		(578,150	)
Long-term debt	$	0		$	25,000

The Company had accrued $18,797 and $52,186 of interest on the notes at April 30, 2013 and January 31, 2013 respectively.

NOTE 4 - STOCKHOLDERS’ EQUITY

Preferred Stock:

The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share. There are no preferred shares outstanding at April 30, 2013 and January 31, 2013.

Common Stock:

The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share. These shares have full voting rights. At April 30, 2013 and January 31, 2013 there were 50,125,528 and 50,125,528 shares outstanding, respectively. No dividends were paid in the quarters ended April 30, 2013 and 2012.

Options and Warrants:

The Company had the following options or warrants outstanding at April 30, 2013:

Issued To	# Options	Dated	Expire	Strike Price
President and CEO	4,000,000	11/18/2010	11/18/2015	$0.25 per share
Vice President	2,000,000	11/18/2010	11/18/2015	$0.25 per share
Shareholder	127500	08/28/2011	08/28/2016	$0.10 per share
Shareholder	50,000	04/04/2012	04/04/2013	$0.20 per share
Shareholder	8,000	04/27/2012	04/27/2013	$0.20 per share

Shareholder	127,500	04/29/2012	04/29/2017	$0.10 per share
Shareholder	200,000	05/17/2012	05/17/2013	$0.20 per share
Shareholder	50,000	05/22/2012	05/22/2013	$0.20 per share
Shareholder	80,000	05/21/2012	05/21/2013	$0.20 per share
Shareholder	25,000	07/12/2012	07/12/2013	$0.20 per share
Shareholder	25,000	07/10/2012	07/10/2013	$0.20 per share
Shareholder	50,000	08/09/2012	08/09/2013	$0.20 per share
Shareholder	1,000,000	08/31/2012	08/31/2016	$0.12 per share
Shareholder	2,000,000	01/18/2013	01/18/2018	$0.12 per share
Shareholder	100,000	03/29/2013	03/29/2016	$0.10 per share
Shareholder	127,500	07/31/2013	07/30/2018	$0.10 per share
Total	6,970,500

NOTE5 – EMPLOYEE BENEFIT PLANS

At April 30, 2013, there were no qualified or non-qualified employee pension, profit sharing, stock option, or other plans authorized for any class of employees.

NOTE 6 – INCOME TAXES

MedCareers Group, Inc. has incurred losses since inception. Therefore, MedCareers has no federal tax liability. Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes. The net deferred tax asset generated by the loss carryforward has been fully reserved. The cumulative net operating loss carryforward is about $4,941,906 at April 30, 2013 of which $3,997,272 is available for carryforward for federal income tax purposes and will expire in fiscal year 2026 through 2028. At April 30, 2013 and January 31, 2013, the deferred tax asset consisted of the following:

	April 30, 2013			January 31, 2013
Deferred tax asset:
Net operating loss	$	1,403,804		$	1,295,736
Less valuation allowance		(1,403,804	)		(1.295,736	)
Net deferred tax asset	$	0		$	0

NOTE 7 – COMMITMENTS AND CONTINGENCIES

The Company may from time to time be involved with various litigation and claims that arise in the normal course of business. As of April 30, 2013, no such matters were outstanding.

NOTE 8 – SUBSEQUENT EVENTS

None.

NOTE 9 - GOING CONCERN

MedCareers’ financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred cumulative losses through April 30, 2013 of $4,941,906 and has a working capital deficit at April 30, 2013 of $944,064.

Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern. The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern. There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it. MedCareers’ financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 10 – RECENT ACCOUNTING PRONOUNCEMENTS

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, which we refer to in this quarterly report as the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, which we refer to in this quarterly report as the Exchange Act. Forward-looking statements are not statements of historical fact but rather reflect our current expectations, estimates and predictions about future results and events. These statements may use words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “predict,” “project” and similar expressions as they relate to us or our management. When we make forward-looking statements, we are basing them on our management’s beliefs and assumptions, using information currently available to us. These forward-looking statements are subject to risks, uncertainties and assumptions, including but not limited to, risks, uncertainties and assumptions discussed in this quarterly report. Factors that can cause or contribute to these differences include those described under the headings “Risk Factors” and “Management Discussion and Analysis and Plan of Operation.”

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Any forward-looking statement you read in this quarterly report reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. All subsequent written and oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by this paragraph. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this quarterly report. The Company expressly disclaims any obligation to release publicly any updates or revisions to these forward-looking statements to reflect any change in its views or expectations. The Company can give no assurances that such forward-looking statements will prove to be correct.

Company.

Medcareers Group, Inc. (“MedCareers”, the “Company”, “we” or “us”), the Company described herein, is a Nevada corporation, with offices located at 758 E Bethel School Road, Coppell, Texas 75019. It can be reached by phone at (972) 393-5892.

History.

The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada Corporation as RX Scripted, Inc. on December 5, 2007. On December 16, 2009, an amendment was filed with the State of Nevada to among other things, change the name of the company to “MedCareers Group, Inc.” and affect a 10 for 1 forward stock split (which became effective January 7, 2010). Unless otherwise stated or the context suggests otherwise, the number of shares disclosed throughout this report have been retroactively reflected for the stock split.

On or around November 19, 2010, the Company entered into a Share Exchange Agreement (the “Exchange”) with Nurses Lounge, Inc., a Texas corporation (“Nurses Lounge”) and the nine shareholders of Nurses Lounge (the “Nurses Lounge Shareholders”). Pursuant to the Exchange, we agreed to issue 24,000,000 restricted shares of our common stock to the Nurses Lounge Shareholders in exchange for 100% of the issued and outstanding shares of common stock of Nurses Lounge. Pursuant to the Exchange, Nurses Lounge became a wholly-owned subsidiary of the Company.

History and Description of the Operations of Nurses Lounge

At the beginning of 2003 in Dallas, Texas, Timothy Armes (our Chief Executive Officer, sole director and largest shareholder) took over control of the nursing internet portal and nursing job board NursesLounge.com and re-launched the web site shortly thereafter. Mr. Armes also launched a localized direct mail magazine as a companion to the website. Years of managing a portal and publishing a monthly magazine gave Mr. Armes insight to numerous organizations in need of a more efficient way to communicate important information to nursing professionals such as news, meetings and continuing education requirements on a timely basis.

With this understanding, and the development of social media technology, Mr. Armes designed and launched a beta version of a professional network for nurses in the summer of 2009 designed to provide a common platform for nursing organizations such as nursing schools, associations and major nurse employers to connect and communicate more effectively to their nurse constituents and broader nursing profession. Additionally, the network was developed to allow individual nurses the ability to interact with these organizations and other professionals via a professional profile separate from a social profile that they may have on Facebook as example.

Today, Nurses Lounge operates as a free online professional network for nursing professionals, and provides a secure place for nurses to connect with colleagues, network on a professional level and subscribe to professional “Lounges” (groups) to receive email updates of relevant news, events and other info.

Interactive Lounges are created primarily by nursing schools, local chapters of nurse associations and major nurse employers. Additionally, Nurses Lounge also has 73 metro/state lounges which aggregate all of the professional nursing news, events and employment opportunities within that certain geographic region.

As a communication utility, Nurses Lounge solves many of the communication issues these organizations face:

·	Local chapters of nurse associations use Nurses Lounge (opposed to outdated, hard to manage static web sites and email lists) as a more efficient way to communicate with their members as well as for recruiting new members and disseminating news and information to their local nursing profession.

·	Nursing Schools benefit with a group in the Nurses Lounge not only as a means to easily distribute news and info, but also to manage and keep alumni notified of educational opportunities as well as providing a professional networking platform between students, faculty and alumni.

·	Employer’s benefits include managing a positive brand, distribution of news, job postings, managing employee referral programs as well as internal communications for things such as shared governance.

There is no cost to schools, associations or other non-profit organizations to utilize the Nurses Lounge communication and networking capabilities while employers, and other for profit organizations, are charged minimal set-up fees that also may include unlimited job postings for a limited time.

Nurses that register with the Nurses Lounge by creating a professional profile are then able to share their perspectives through their participation in these groups in order to keep current on news, information, meetings and jobs openings as well as to network professionally with like-minded colleagues. Participation and postings by members in Lounges creates new connections and makes it easier for people to find and connect with each other. Finally, by inviting new colleagues and contacts to join them in the Nurses Lounge, members both grow their own network of connections and help to increase membership in Nurses Lounge.

Along with the professional network, Nurses Lounge has a fully functional job board for nursing professionals as well as a nursing faculty job board specialty site for nursing schools looking to hire faculty. This specialty site was launched in June 2012.

The faculty job board was launched in response to the increasing number of schools joining our network and adding their faculty and graduate degree nurses coupled with a growing shortage of nursing faculty.

To date Nurses Lounge, with no dedicated sales force or marketing campaign, has generated small amounts of job posting revenue from these job sites as well as from employers and other for profit organizations paying set-up fees for activating their interactive lounges.

Plans Moving Forward

The Company previously operated as an event planning consulting company engaged in the planning and execution of medical meetings and educational programs for nurses, physicians, pharmacists and other healthcare professionals. Subsequent to the acquisition of Nurses Lounge, we have focused solely on Nurses Lounge, and have discontinued and spun-off the event planning and consulting operations as of November 30, 2010.

Moving forward in the near term, management intends to concentrate on growing individual nurse membership by adding Nursing Schools, Student Nurse Associations and Professional Nurse Associations to our network.

We expect to do this by introducing these organizations to and educating them on the benefits that our network offers. Specifically in terms of providing them a free, branded turn-key solution for instant communications of news and information to their constituents as well as increased exposure for their organization to the broader nursing profession.

As these organizations join our network they invite their members to join their “interactive lounge”. As an example, the University of Texas at Arlington College of Nursing to date has had over 900 students, alumni and faculty connect with them in the Nurses Lounge via an invitation sent from the Dean of their nursing school as well as Nurses Lounge “NL” icon they have placed on their web site.

We also intend to strengthen our brand and grow membership through increased marketing efforts and expanded and enhanced features and functionalities over time, funding permitting.

Additionally, as membership grows, management will look to diversify the revenue model from primarily job posting revenue. Potential income streams are expected to include targeted banner ads, email sponsorships, Groupon type sales as well as mobile apps.

With funds permitting, to support these revenue streams and grow our network, management will be looking to hire 12-15 “regional publishers” as well as marketing support personnel. These publishers will be responsible for revenue generation and membership growth in their assigned markets.

We are currently considering offerings of securities under private placements, acquisitions (which are directly related to Nurses Lounge), issuing debt instruments, and joint ventures with other companies public and private and other activities to either build sales or generate much needed capital to grow and undertake our business plan (for example, obtain, if possible, loans). However, we do not currently have any lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt securities and loans from our shareholders and other third parties.

Our financial statements contain information expressing substantial doubt about our ability to continue as a going concern. The consolidated financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we satisfy our liabilities and commitments in the ordinary course of business.

Moving forward throughout fiscal year 2014, we hope to expand our services into providing Student Nurse Associations (SNAs), a needed professional communication platform that will allow them to help communicate more efficiently with current members while additionally building their organizations membership. Additionally, with our administration and after our SEC reporting obligations are current, we will be positioned to spend the majority of any equity raised to build a national sales team with needed sales and marketing. The Company estimates it needs $750,000 to fully implement its business plan. However, the Company can support its operations for 90 days with its cash on hand.

Recent Activity

From the launch of the Nurses Lounge network in 2009 through the year ending January 31, 2011 Nurses Lounge focused on working with organizations around the Dallas Fort Worth, Texas area. This process and time allowed us to better understand the communication needs and desires of these organizations and provided us the insight on how best to structure the network to meet the communication needs of our target markets across the nation.

During the fiscal year ending January 31, 2012, with 2 full time employees, Nurses Lounge concentrated on building out the network by creating 73 metro lounges representing all the major metro areas and/or states across the U.S. Additionally we created over 500 “interactive lounges” for Bachelor of Science in Nursing (BSN) schools across the nation and positioned ourselves for a national rollout as funds became available.

During the fiscal year that ended January 31, 2013 we began marketing to BSN schools and selected associations across the U.S.

Additionally we launched a “Nursing Faculty” specialty job site in June of 2012. This was done based on the numerous experienced faculty members and educationally qualified nurses (MSN and PhD candidates) that were joining our network as well as the growing demand for nursing faculty across the U.S. Additionally management found very little direct competition in the space.

***

Results for the three months ended April 30, 2013

Revenue. Revenue for the three months ended April 30, 2013 and 2012 was $5,735 and $2,045.

Cost of Revenues. Cost of revenues were $16,133 and $4,964 for the three months ended April 30, 2013 and 2012 respectively The increase in costs was due to the operation of its websites which started generating revenue.

Operating Expenses. Operating expenses for the three months ended April 30, 2013 and 2012 were $157,090 and $101,856 respectively. The above expenses include depreciation and amortization amounts of $41,937 and $33,000 for the three months ended April 30, 2013 and 2012, respectively.

Other Income (Expense). Other income represents interest paid or accrued on loans which was $18,797 and $16,149 for the three months ended April 30, 2013 and 2012, respectively.

Liquidity and Capital Resources

As of April 30, 2013, the Company had total current assets of $32,103, and total long-term assets of $50,280 consisting of deferred fees of $50,280 relating to consideration paid for making or extending loans. We had total liabilities of $976,167, which were all current liabilities, They included accounts payable of $10,625, accrued expenses of $2,838, amounts due to related party of $215,424, which amounts were due to Tim Armes and Garrett Armes and have the following terms, due on demand, accrued interest payable of $106,630 and $640,650 of current portion of long-term debt in connection with working capital loans.

As of April 30, 2013, the Company had negative working capital of $944,064, comprised of current assets of $32,103 and current liabilities of $976,167.

Net cash used in operations for the three months ended April 30, 2013 was $96,462 compared to $18,362 for the three months ended April 30, 2012.

Cash provided from or used for investing activities was $0 in the three months ended April 30, 2013 and $0 for the same period in 2012.

Cash provided by financing activities for the three months ended April 30, 2013 was $37,500 compared to $17,500 for the same period in 2012.

On or around March 2, 2010, we entered into a Letter of Intent to acquire the Uniform Resource Locator (“URL”) www.WorkAbroad.com (“WorkAbroad.com” and the “Purchase”). The purchase price was $225,000 (the “Purchase Price”). On March 8, 2010, the Company paid the required 10% down payment (equal to $22,500) on the purchase price to Steve Elisberg (the “Seller”). The remaining balance due ($202,500) pursuant to the Purchase was payable at a rate of $2,248 per month, beginning in April 2010, based on a 10 year amortizing loan with interest at 6% with a balloon payment of all unpaid principal and interest due 36 months after closing (the “Loan”). The parties entered into a definitive Asset Purchase Agreement on August 10, 2010 and a formal closing of the Purchase occurred on August 10, 2010. The Company made the initial payment to the Seller in March 2010 so that it could assume operations of WorkAbroad.com at the time of the parties’ entry into the Letter of Intent rather than waiting for the formal closing.

The repayment of the Loan was secured by a security interest over WorkAbroad.com. Since the closing of the Nurses Lounge acquisition, Timothy Armes, the controlling shareholder of the Company decided to terminate pursuit of the previously disclosed acquisition opportunities so that the Company could focus on developing Nurses Lounge and businesses that are complementary to Nurses Lounge.

In connection therewith on July 8, 2011, the Company entered into an Asset Purchase Agreement with Fiakow Properties, LLC (“Fiakow”, pursuant to which Fiakow purchased the Company’s entire right and interest in workabroad.com and the August 10, 2010 Asset Purchase Agreement for an aggregate of $1,000, provided that the Seller did not formally release the Company from liability in connection with the August 10, 2010 Asset Purchase Agreement and the Loan, which Loan has been repaid in full as of the date of this filing.

On November 4, 2010, the Company obtained a $100,000 loan from a third party, which was evidenced by a Promissory Note. The note bears interest at the rate of 12% per annum, payable monthly in arrears, and has a maturity date of November 4, 2011. The repayment of the note is secured by a security interest in substantially all of the Company’s assets. In consideration for making the loan, the Company agreed to issue the third party 400,000 shares of restricted common stock. The stock issued had a value of $60,000 on the date of the grant, based on the closing trading price on November 4, 2010. The $60,000 is treated as a discount on the loan. Accordingly, the loan will be reflected as a liability of $40,000 and the $60,000 discount will be reduced pro rata over the term of the loan as additional interest expense on the note and added to the loan balance on a monthly basis.

On February 8, 2011, the Company obtained a $70,000 loan from a third party, which was evidenced by a Promissory Note. The note bears interest at the rate of 12% per annum, payable monthly in arrears, and has a maturity date of February 15, 2012. In consideration for making the loan, the Company agreed to issue the third party 100,000 shares of restricted common stock. The loan will be funded in three installments: $30,000 on or before February 10, 2011; $20,000 on or before February 24, 2011; and $20,000 on or before March 10, 2011. The stock issued had a value of $18,200 on the date of the grant, based on the closing trading price on February 8, 2011. The $18,200 is treated as a discount on the loan. Accordingly, the loan will be reflected as a liability of $51,800 and the $18,200 discount will be reduced pro rata over the term of the loan as additional interest expense on the note and added to the loan balance on a monthly basis.

The Company has borrowed funds and/or sold stock for working capital. These transactions are detailed in the section “Recent Sales of Unregistered Securities”.

Currently the Company does not have sufficient cash reserves or revenues to meet its contractual obligations under its outstanding notes payable and to pay its ongoing monthly expenses, which the Company anticipates totaling approximately $250,000 over the next 12 months. The Company has been able to continue operating to date largely from loans made by its shareholders and other debt financings to date. The Company is currently looking at both short-term and more permanent financing opportunities, including debt or equity funding, bridge or short term loans, and/or traditional bank funding, but we have not decided on any specific path moving forward. Until we have raised sufficient funding to pay our ongoing expenses associated with being a public company, and we have sufficient funds to support our planned operations, the Company can provide no assurances that it will be able to meet its short and long term liquidity needs, until necessary financing is secured. The Company has started to generate revenue from the Nurses Lounge business in 2011, which the Company hopes will increase to the point where the Company can finance at least a substantial portion of the Company’s obligations, of which there can be no assurance.

We do not currently have any additional formal commitments or identified sources of additional capital from third parties or from our officers, director or significant shareholders. We can provide no assurance that additional financing will be available on favorable terms, if at all. If we are not able to raise the capital necessary to continue our business operations, we may be forced to abandon or curtail our business plan.

In the future, we may be required to seek additional capital by selling additional debt or equity securities, selling assets, if any, or otherwise be required to bring cash flows in balance when we approach a condition of cash insufficiency. The sale of additional equity or debt securities, if accomplished, may result in dilution to our then shareholders. We provide no assurance that financing will be available in amounts or on terms acceptable to us, or at all.

ITEM 3. Quantitative and Qualitative Disclosure about Market Risk.

Pursuant to Item 305(e) of Regulation S-K (§ 229.305(e)), we are not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

ITEM 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Principal Financial Officer, after evaluating the effectiveness of our "disclosure controls and procedures" (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"), has concluded that as of the Evaluation Date, our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Moving forward, we hope that our Chief Executive Officer and Principal Financial Officer will be able to devote the additional time and effort required so that our disclosure controls and procedures are once again effective. Notwithstanding the assessment that our internal controls and procedures were not effective, we believe that our financial statements contained in this Quarterly Report for the quarter ended April 30, 2013 fairly present our financial position, results of operations and cash flows for the years and months covered thereby in all material respects.

(b) Changes in internal control over financial reporting. There were no changes in our internal control over financial reporting during our most recent fiscal quarter that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

PART II

Item 1. Legal Proceedings

From time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the year ended January 31, 2013, filed with the Commission on September 23, 2013, other than as set forth below, and investors are encouraged to review such risk factors below and in the Form 10-K, prior to making an investment in the Company.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Securities

	Consideration		Date	# Shares
Balance, Number of shares outstanding, January 31, 2013				50,125,528
Shares issued for deferred fees	Incentive for new loan	(1)	Feb, 2013	600,000
Shares issued for deferred fees	Incentive for new loan	(2)	July 19, 2013	200,000
Shares issued for deferred fees	Incentive for new loan	(3)	July 31, 2013	166,667
Shares issued for deferred fees	Incentive for new loan	(4)	July 31, 2013	133,334
Shares issued for deferred fees	Incentive for new loan	(5)	July 31, 2013	133,334
Shares issued for deferred fees	Note extension	(6)	July 31, 2013	1,100,000
Shares issued for note conversion	Convert $25,000 note	(7)	Aug 5, 2013	250,000
Balance, Number of shares outstanding, September 5, 2013				52,708,863

(1) 600,000 Shares Restricted common stock issued as compensation for engagement term for one year of Consultant's (Inspire Value) services valued at $5,000 per month or $60,000 total. The stock was issued with an agreed upon value of $0.10 per share. The value of these shares were determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

The Company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.

(2) 200,000 total shares issued on July 19, 2013 in consideration for lending the Company $30,000, note dated July 19, 2013, 12% annual interest rate, due October 31, 2013, Jamie Bernard was issued a total of 200,000 shares of restricted common stock. Additionally, the note is convertible at $0.10 per share. The value of these shares were determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

(3) 166,667 shares were issued on 7/31/2013 in consideration for lending the Company $25,000, note dated July 31, 2013, 12% annual interest rate, due Oct 31, 2013. Additionally, the note is convertible at $0.10 per share. The value of these shares was determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

(4) 133,334 shares were issued on 7/31/2013 in consideration for lending the Company $20,000, note dated July 31, 2013, 12% annual interest rate, due Oct 31, 2013. Additionally, the note is convertible at $0.10 per share. The value of these shares was determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

(5) 133,334 total shares issued on 7/31/2013, In consideration for lending the Company $20,000, note dated July 31, 2013, 12% annual interest rate, due Oct 31, 2013 - the note was converted on August 5, 2013. Additionally, the note is convertible at $0.10 per share. The value of these shares was determined on the day of agreement and booked in the financial statement as Deferred Fees and amortized over the life of the loan.

(6) 1,100,000 shares issued on 7/31/2013 in consideration for extending his original note a second time with his original note dated November 4, 2010 and due November 4, 2011 and then renewed and due November 4, 2012 and additionally renewed a second time and due November 4, 2013 in the amount of $100,000 for an additional year. The value of these shares was determined on the day of agreement and booked in the financial statements as Deferred Fees and amortized over the life of the loan.

(7) Conversion of Note dated July 31, 2013 that had a conversion feature at $.10 per share. These shares were issued for the conversion of a $25,000 note.

Options and Warrants

(8) Three options for 127,500 shares of restricted common stock at an exercise price of $0.10 per share and for a term of 5 years was awarded Geneva7, LLC in consideration for loaning the Company $25,000 and renewing the note two additional times. Geneva7, LLC originally loaned the Company $25,000 at 12% interest on August 29, 2011 and was awarded an option to purchase 127,500 shares of restricted common stock at an exercise price of $0.10. The term of the option is 5 years. The loan matured on April 30th 2012 and Geneva 7 agreed to renew the loan and accrue interest thru July 31, 2013 and additionally renewed the loan thru October 31, 2013 when it matured on July 31, 2013. With each additional renewal Geneva7 received an additional option to purchase 127,500 shares of restricted common stock at an exercise price of $0.10 per share and for a term of 5 years.

(9) Warrant to purchase 1,000,000 shares. The Company entered into a contract for services with Horse and Hammerhead Marketing Solutions, LLC, a management consulting firm. Based on the agreement, the consultant was issued a warrant for 1,000,000 shares of MCGI’s restricted common stock at an exercise price of $0.12 per/share with a 4-year term.

(10) Warrant to purchase 100,000 shares. The Company entered into a contract for services with EBCO, LLC. Based on the agreement, in consideration for extending their $16,000 loan, they were issued a warrant for 100,000 shares of MCGI’s restricted common stock at an exercise price of $0.10 per/share, expiring March 29, 2016.

Item 3. Default Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

See the Exhibit Index immediately following the signature page of this Report on Form 10-Q.

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Medcareers Group, Inc.

By: /s/ Timothy Armes

Timothy Armes

Chairman (Director), Chief Executive Officer, President, Secretary and Treasurer

(Principal Executive Officer and Principal Financial/Accounting Officer)

Date: September 24, 2013

EXHIBIT INDEX

Exhibit Number	Description of Exhibit

3.1(1)	Articles of Incorporation

3.2(5)	Certificate of Amendment to Articles of Incorporation

3.3(5)	Certificate of Correction to Certificate of Amendment to Articles of Incorporation

3.2(1)	Bylaws

10.1(1)	Revolving Credit Promissory Note with Kevin McAdams (December 12, 2007)

10.2(1)	Convertible Promissory Note with David M. Loev (March 11, 2008)

10.3(2)	Amended Convertible Promissory Note with David M. Loev

10.4(3)	Amended Revolving Credit Promissory Note with Kevin McAdams

10.5(3)	Second Amended Convertible Promissory Note with David M. Loev

10.6(4)	Stock Purchase Agreement

10.7(4)	Voting Agreement

10.8(4)	Debt Extinguishment Agreement (Kevin McAdams)

10.9(4)	Debt Extinguishment Agreement (David M. Loev)

10.10(6)	Agreement with Premier Healthcare Professionals, Inc.

10.11(7)	Promissory Note

10.12(8)	Asset Purchase Agreement Relating to the Purchase of WorkAbroad.com

10.13(8)	WorkAbroad.com Development Proposal

10.14(9)	Share Exchange Agreement with Nurses Lounge and the Shareholders of Nurses Lounge

10.15(9)	Cancellation of Shares Agreements

10.16(9)	Voting Agreement

10.17(9)	Employment Agreement with Timothy Armes (Nurses Lounge)

10.18(9)	Option Agreement with Garret Armes

10.19(9)	Option Agreement with Timothy Armes

10.20(9)	Spin-Off Agreement

10.21(9)	$190,000 Promissory Note

10.22(9)	$100,000 Promissory Note

10.23(10)	$50,000 Promissory Note

10.24(13)	Asset Purchase Agreement workabroad.com (July 8, 2011)

10.25(13)	Employment Agreement (Timothy Armes)( November 18, 2010)

10.26(13)	Employment Agreement (Garret Armes)(November 18, 2010)

10.27(13)	Common Stock Purchase Option (Timothy Armes)(November 18, 2010)(4,000,000 shares)

10.28(13)	Common Stock Purchase Option (Garret Armes)(November 18, 2010)(2,000,000 shares)

16.1(11)	Letter from GBH CPAs, PC dated March 29, 2013

31.1*	Certificate of the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**	Certificate of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

99.1(8)	Financial Statements of WorkAbroad.com

99.2(8)	Pro Forma Financial Information of WorkAbroad.com

99.3(12)	Audited Balance Sheets of Nurses Lounge as of October 31, 2010 and December 31, 2009; Audited Statement of Operations of Nurses Lounge for the ten months ended October 31, 2010, year ended December 31, 2009 and cumulative period since re-entering the development stage on January 1, 2009; Audited Statement of Partners’ Capital of Nurses Lounge for the year ended December 31, 2009 and ten months ended October 31, 2010; and Audited Statements of Cash Flows of Nurses Lounge for the ten months ended October 31, 2010, year ended December 31, 2009 and cumulative period since re-entering the development stage on January 1, 2009, and the notes thereto

99.4(12)	Unaudited Pro Forma Condensed Statement of Operations for the nine months ended October 31, 2010 and Unaudited Pro Forma Condensed Balance Sheet as of October 31, 2010, and the notes thereto

* Filed herewith.

** Furnished herewith.

(1) Filed as Exhibits to the Company’s Registration Statement on Form S-1 filed with the Commission on July 22, 2008, and incorporated herein by reference.

(2) Filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q filed with the Commission on December 19, 2008, and incorporated herein by reference.

(3) Filed as an Exhibit to the Company’s Annual Report on Form 10-K filed with the Commission on May 8, 2009, and incorporated herein by reference.

(4) Filed as an Exhibit to the Company’s Current Report on Form 8-K filed with the Commission on October 9, 2009, and incorporated herein by reference.

(5) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on January 7, 2010, and incorporated herein by reference.

(6) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on May 7, 2010, and incorporated herein by reference.

(7) Filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q, filed with the Commission on May 14, 2010, and incorporated herein by reference.

(8) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on August 11, 2010, and incorporated herein by reference.

(9) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on December 2, 2010, and incorporated herein by reference.

(10) Filed as an Exhibit to the Company’s Quarterly Report on Form 10-Q, filed with the Commission on March 11, 2011, and incorporated herein by reference.

(11) Filed as an Exhibit to the Company’s Current Report on Form 8-K, filed with the Commission on March 29, 2011, and incorporated herein by reference.

(12) Filed as an Exhibit to the Company’s Current Report on Form 8-K/A, filed with the Commission on August 16, 2013, and incorporated herein by reference.

(13) Filed as an Exhibit to the Company’s Annual Report on Form 10-K, filed with the Commission on September 3, 2013, and incorporated herein by reference.

EX-31.1 2 ex31one.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Timothy Armes, certify that:

I have reviewed this report on Form 10-Q of MEDCAREERS GROUP, INC.;
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusion about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

Disclosed in this report any change to the registrant's internal controls over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal controls over financial reporting; and,

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and,

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: September 24, 2013

/s/ Timothy Armes

Timothy Armes

Chief Executive Officer

(Principal Executive Officer and Principal Financial/Accounting Officer)

EX-32.1 3 ex32one.htm CERTIFICATION

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Timothy Armes, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of MedCareers Group, Inc. on Form 10-Q for the period ended April 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of MedCareers Group, Inc.

By:/s/ Timothy Armes

Timothy Armes

Chief Executive Officer

(Principal Executive Officer and Principal Financial/Accounting Officer)

September 24, 2013

EX-101.INS 4 mcgi-20130131.xml XBRL INSTANCE FILE 0001438901 2013-02-01 2013-04-30 0001438901 2013-09-05 0001438901 2013-04-30 0001438901 2012-04-30 0001438901 2012-02-01 2012-04-30 0001438901 2009-04-01 2013-04-30 0001438901 2013-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares MEDCAREERS GROUP, Inc. 0001438901 10-Q 2013-01-31 false --01-31 No No No Smaller Reporting Company Q1 2013 52708863 52708863

30718

89680

1799

50280

92217

82383

181897

10625

6918

2838

11852

215424

178143

106630

89333

640650

578150

976167

864396

640650

603150

-640650

-578150

25000

976167

889396

50126

50125

3997996

3997997

-4941906

-4755621

-893784

-707499

82383

181897

NOTE 1 NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES   Nature of Activities, History and Organization  The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007.  On December 16, 2009, an amendment was filed with the State of Nevada to change the name to MedCareers Group, Inc. (the Company or MedCareers) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (Nurses Lounge), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers. As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers. The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company. The share exchange was treated as a recapitalization of MedCareers. As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital.  The Company operates a website for nurses, nursing schools and nurses organizations which enables the respective entities to communicate more easily and efficiently with their members. Significant Accounting Policies: The Companys management selects accounting principles generally accepted in the United States of America and adopts methods for their application.  The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements. The financial statements and notes are representations of the Companys management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud.  The Company's system of internal  accounting control is designed to assure, among other items, that  1) recorded  transactions  are valid;  2) valid  transactions  are recorded;  and  3) transactions  are  recorded in the proper  period in a timely  manner to produce financial  statements which present fairly the financial  condition,  results of operations  and cash  flows of the  Company  for the  respective  periods  being presented. Basis of Presentation: The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States. Principles of Consolidation: The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc.  All significant inter-company transactions have been eliminated.  All amounts are presented in U.S. Dollars unless otherwise stated. Development Stage Company:   The Company complies with ASC No. 915-10 for its characterization of the Company as development stage. Cash and Cash Equivalents: The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents.  At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (FDIC) insurance limits.  The carrying amount approximates fair market value. Fixed Assets: Fixed assets are carried at cost.  Depreciation is provided over each assets estimated useful life.  Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income.   Additions and significant improvements are capitalized and depreciated. Advertising Costs: The Company incurred no advertising costs for the years ended January 31, 2013 and 2012. Income Taxes: Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code.  Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration.  Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Use of Estimates: In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. Fair Value of Financial Instruments:   Pursuant to ASC No. 820, Fair Value Measurements and Disclosures, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of January 31, 2013.  The Companys financial instruments consist of cash, accounts payable, advances and notes payable.  The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.   Revenue Recognition:   Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned.  The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured.  For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (SAB 104)).   Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable. Earnings per Common Share: Earnings (loss) per share are calculated in accordance with ASC 260 Earnings per Share.   The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share.  Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding.   Dilutive potential common shares are additional common shares assumed to be exercised.     Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive. There were no potentially dilutive common stock equivalents as of January 31, 2013, therefore basic earnings per share equals diluted earnings per share for the year ended January 31, 2013.  The Company had 9,743,000 options outstanding at January 31, 2013. As the Company incurred a net loss during the year ended January 31, 2013, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive. Recently Issued Accounting Pronouncements: The Company  does not expect  the  adoption  of  recently  issued  accounting pronouncements  to have a significant  impact on the Companys  results of  operations, financial position or cash flows.

NOTE 2 DEFERRED FEES   Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at January 31, 2013 and 2012 were as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding: 1.5pt; text-align: justify"> </td> <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2013</td> <td style="padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2012</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Deferred Fees</td> <td style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">614,170</td> <td style="vertical-align: bottom; border-top: black 1pt solid"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">304,200</td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Less: Accumulated Amortization</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(521,953</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid">)</td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(190,367)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Deferred Fees - Net</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">92,217</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">113,833</td></tr> </table>

NOTE 3 - NOTES PAYABLE   The components of the Companys debt as of January 31, 2013 and 2012 were as follows: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding: 1.5pt; text-align: justify"> </td> <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2013</td> <td style="padding: 1.5pt; text-align: right"> </td> <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2012</td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$ 100,000</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right">  $</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">100,000</td> <td style="vertical-align: top"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $190,000, 12% interest payable monthly or accrued, due Oct 29, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">288,150</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">240,000</td> <td style="vertical-align: top"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: top"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">16,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">16,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">70,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">70,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $40,000, 12% interest added to note quarterly, due April 28, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">40,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">40,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">4,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">4,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $30,000, 12% interest added to note quarterly, due Nov 5, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">30,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">0</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $5,000, 12% interest added to note quarterly, due Nov 5, 2013</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">5,000</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">0</td> <td style="vertical-align: top; border-bottom: black 1pt solid"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Subtotal</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">603,150</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">520,000</td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Less currently payable</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(578,150)</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(495,000)</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Long-term debt</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">   25,000</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double"> </td></tr> <tr> <td style="width: 80%"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td></tr> </table>   The Company had accrued $89,333 and $36,046 interest on the notes at January 31, 2013 and 2012, respectively.

NOTE 4 - STOCKHOLDERS EQUITY Preferred Stock: The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.  There are no preferred shares outstanding at January 31, 2013 and 2012. Common Stock: The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.  These shares have full voting rights.  At January 31, 2013 and 2012, there were 50,125,028 and 43,315,000 shares outstanding, respectively.  No dividends were paid in the years ended January 31, 2013 or 2012.   Options and Warrants: The Company had the following options or warrants outstanding at January 31, 2013:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 21%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Issued To</td> <td style="width: 16%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"># Options</td> <td style="width: 20%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Dated</td> <td style="width: 19%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Expire</td> <td style="width: 24%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Strike Price</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">President and CEO</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vice President</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2011</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2017</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">200,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">80,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2018</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> </table>

NOTE 4 - STOCKHOLDERS EQUITY Preferred Stock: The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.  There are no preferred shares outstanding at January 31, 2013 and 2012. Common Stock: The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.  These shares have full voting rights.  At January 31, 2013 and 2012, there were 50,125,028 and 43,315,000 shares outstanding, respectively.  No dividends were paid in the years ended January 31, 2013 or 2012.   Options and Warrants: The Company had the following options or warrants outstanding at January 31, 2013:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 21%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Issued To</td> <td style="width: 16%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"># Options</td> <td style="width: 20%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Dated</td> <td style="width: 19%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Expire</td> <td style="width: 24%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Strike Price</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">President and CEO</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vice President</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2011</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2017</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">200,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">80,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2018</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> </table>

NOTE 6 INCOME TAXES   MedCareers Group, Inc. has incurred losses since inception.  Therefore, MedCareers has no federal tax liability.  Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes.  The net deferred tax asset generated by the loss carryforward has been fully reserved.  The cumulative net operating loss carryforward is about $4,755,621 at January 31, 2012 of which $3,810,987 is available for carryforward for federal income tax purposes and will expire in fiscal years 2026 to 2028.  At January 31, 2013 and 2012, the deferred tax asset consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td colspan="2" style="text-align: center">2013</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center">2012</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Deferred tax asset:</td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td nowrap="nowrap" style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td nowrap="nowrap" style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 59%; text-align: justify">   From Net operating loss</td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 2%; text-align: justify">$   </td> <td style="width: 15%; text-align: right"> 837,432</td> <td nowrap="nowrap" style="width: 1%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 3%; text-align: justify">$</td> <td style="width: 14%; text-align: justify"> 837,432</td> <td nowrap="nowrap" style="width: 4%; text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify">   Less valuation allowance</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(837,432</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: justify">)</td> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">(837,432</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: justify">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 3pt; text-align: justify">   Net deferred tax asset</td> <td style="padding-bottom: 3pt; text-align: justify"> </td> <td style="border-bottom: black 2.25pt double; text-align: justify">$</td> <td style="border-bottom: black 2.25pt double; text-align: justify">             0</td> <td nowrap="nowrap" style="padding-bottom: 3pt; text-align: justify"> </td> <td style="padding-bottom: 3pt; text-align: justify"> </td> <td style="border-bottom: black 2.25pt double; text-align: justify">$</td> <td style="border-bottom: black 2.25pt double; text-align: justify">            0</td> <td nowrap="nowrap" style="padding-bottom: 3pt; text-align: justify"> </td></tr> </table>

NOTE 7 COMMITMENTS AND CONTINGENCIES   The Company may from time to time be involved with various litigation and claims that arise in the normal course of business.  As of January 31, 2013, no such matters were outstanding.

NOTE 8 - GOING CONCERN AND FINANCIAL POSITION   MedCareers financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.  The Company has incurred cumulative losses through January 31, 2013 of $4,755,621 and has a working capital deficit at January 31, 2013 of $774,716.   Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern.  The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern.  There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it.  MedCareers financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 9 RECENT ACCOUNTING PRONOUNCEMENTS The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Companys results of operations, financial position or cash flows.

NOTE 10 LOSS ON RECAPITALIZATION   On November 5, 2010, the Company effected a recapitalization by issuing 24,000,000 shares of its Common Stock in exchange for 100% of Nurses Lounge, Inc. (Nurses Lounge), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers. Additionally, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers.  The transaction was regarded as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company.  The share exchange was treated as a recapitalization of MedCareers.  As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital  The loss on recapitalization of $223,454 represents the adjustment relating to the value recorded in the equity section of MedCareers pre-recapitalization and the value assigned to it upon recapitalization.

0.001

10000000

0.001

350000000

50126000

50125000

1385

5735

2045

46899

16133

4964

126847

-10398

-2919

-79948

41397

33000

589717

12608

1774

97029

102545

67082

2917470

157090

101856

3604216

-167488

-104775

-3684164

-4087

223454

18797

16149

357299

-18797

-16149

-584840

0.00

50125528

43350112

-186285

-120924

-4269004

25826

41937

33000

563890

165000

0 10347 1986017

-1385

-300

-1365

3707

-5652

18845

25614

23767

117960

19950

41400

198093

-96462

-18362

-1134564

-215453

-191026

-24427

37500

5000

615650

12500

322000

246670

-185939

209429

-35731

16000

37500

17500

1188079

-58962

-862

29088

57740

0 0 165000

884741

614170

EX-101.SCH 5 mcgi-20130131.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Note 1 - Nature of Activities and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Note 2 - Deferred Fees link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Note 3 - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Note 4 - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Note 5 - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Note 6 - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Note 7 - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Note 8 - Going Concern and Financial Position link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Note 9 - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Note 10 - Loss on Recapitalization link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 mcgi-20130131_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 mcgi-20130131_def.xml XBRL DEFINITION FILE EX-101.LAB 8 mcgi-20130131_lab.xml XBRL LABEL FILE Common Stock Equity Components [Axis] Paid-In Capital Retained Earnings (Deficit) Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Other Current Assets Property, Plant and Equipment: Equipment Less: Accumulated depreciation Total Fixed Assets Other Assets: Deferred Fees (net) TOTAL ASSETS LIABILITIES AND EQUITY Current Liabilities: Accounts Payable Accrued Expenses Accounts Payable - Related Parties Accrued Interest Payable Current portion of notes payable Total Current Liabilities Long Term Liabilities: Notes Payable Less: Current Potion Total Long Term Liabilities Total Liabilities Equity: Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 1,000 and 1,000 shares issued and outstanding Common Stock, $0.001 par value, 350,000,000 shares authorized. 50125000 and 43,315,000 shares issued and outstanding Additional Paid In Capital Accumulated Deficit TOTAL STOCKHOLDERS' EQUITY (DEFICIT) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Preferred stock, par or stated value Preferred stock, shares authorized Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of Sales Gross Profit (Loss) Operating Expenses: Depreciation and Amortization Selling and Marketing General and Administrative Total Operating Expenses Net Operating Loss Other Income (Expense): Loss on Disposal of Assets Loss on Recapitalization Interest Expense Total Other Income (Expense) Net Loss Weighted Average Shares Outstanding, Basic and Diluted Basic and Diluted Earnings (Loss) per Share Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used (provided) by operating activiites Depreciation of Property and Equipment Amortization of Deferred Fees Shares Issued for Services Stock Option Expense Changes in assets and liabilities: (Increase) in Other Current Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Expenses Increase (Decrease) in Accrued Expenses - Realted Party Net Cash Provided (Used) by Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of Fixed Assets Sale of Fixed Assets Net Cash Provided (Used) by Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from Notes Payable Payments on Notes Payable Proceeds from Sale of Common Stock Debt Assumed in Acquisition Debt Assumed by Buyer In Asset Sale Interest Added to Notes Payable Common Stock Issued on Recapitalization Net Cash Provided by Financing Activities NET INCREASE (DECREASE) IN CASH AND CASH EQUAVILENTS CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS AT END OF PERIOD SUPPLEMENTAL DISCLOSURES Cash Paid During the Year for Interest Expense Cash Paid During the Year for Taxes Issuance of Common Shares for Services Issuance of Common Stock for Debt Issuance of Common Stock for Fees Accounting Policies [Abstract] Note 1 - Nature of Activities and Significant Accounting Policies Note 2 - Deferred Fees Debt Disclosure [Abstract] Note 3 - Notes Payable Equity [Abstract] Note 4 - Stockholders' Equity Compensation and Retirement Disclosure [Abstract] Note 5 - Employee Benefit Plans Schedule of Investments [Abstract] Note 6 - Income Taxes Commitments and Contingencies Disclosure [Abstract] Note 7 - Commitments and Contingencies Organization, Consolidation and Presentation of Financial Statements [Abstract] Note 8 - Going Concern and Financial Position Note 9 - Recent Accounting Pronouncements Business Combinations [Abstract] Note 10 - Loss on Recapitalization Issuance of Common Stock Options for goods or services. Issuance of Common Stock for Services Performed Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Capital Lease Obligations Debt, Current Liabilities Liabilities and Equity Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Outstanding Common Stock, Shares Authorized Other General Expense Interest Expense Proceeds from Sale of Property, Plant, and Equipment EX-101.PRE 9 mcgi-20130131_pre.xml XBRL PRESENTATION FILE XML 10 R8.xml IDEA: Note 3 - Notes Payable 2.4.0.800000008 - Disclosure - Note 3 - Notes Payabletruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_DebtDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Debt Disclosure [Abstract]2false 2us-gaap_DebtDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 3 - NOTES PAYABLE   The components of the Companys debt as of January 31, 2013 and 2012 were as follows: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding: 1.5pt; text-align: justify"> </td> <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2013</td> <td style="padding: 1.5pt; text-align: right"> </td> <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2012</td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$ 100,000</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right">  $</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">100,000</td> <td style="vertical-align: top"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $190,000, 12% interest payable monthly or accrued, due Oct 29, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">288,150</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">240,000</td> <td style="vertical-align: top"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: top"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">16,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">16,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">70,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">70,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $40,000, 12% interest added to note quarterly, due April 28, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">40,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">40,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">4,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">4,000</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $30,000, 12% interest added to note quarterly, due Nov 5, 2013</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">30,000</td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">0</td> <td style="vertical-align: top; border-bottom: black 1pt solid; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: right">Note Payable - $5,000, 12% interest added to note quarterly, due Nov 5, 2013</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">5,000</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">0</td> <td style="vertical-align: top; border-bottom: black 1pt solid"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Subtotal</td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">603,150</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">520,000</td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Less currently payable</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(578,150)</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(495,000)</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Long-term debt</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">25,000</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">   25,000</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double"> </td></tr> <tr> <td style="width: 80%"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td></tr> </table>   The Company had accrued $89,333 and $36,046 interest on the notes at January 31, 2013 and 2012, respectively. falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20, 22 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20,22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0Note 3 - Notes PayablefalseNote 3 - Notes PayableUnKnownUnKnownUnKnownUnKnowntruefalsefalseNoteshttp://nurseslounge.com/role/Note3-NotesPayable12 XML 11 R6.xml IDEA: Note 1 - Nature of Activities and Significant Accounting Policies 2.4.0.800000006 - Disclosure - Note 1 - Nature of Activities and Significant Accounting Policiestruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Accounting Policies [Abstract]2false 2us-gaap_BasisOfAccountingPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 1 NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES   Nature of Activities, History and Organization  The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007.  On December 16, 2009, an amendment was filed with the State of Nevada to change the name to MedCareers Group, Inc. (the Company or MedCareers) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (Nurses Lounge), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers. As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers. The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company. The share exchange was treated as a recapitalization of MedCareers. As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital.  The Company operates a website for nurses, nursing schools and nurses organizations which enables the respective entities to communicate more easily and efficiently with their members. Significant Accounting Policies: The Companys management selects accounting principles generally accepted in the United States of America and adopts methods for their application.  The application of accounting principles requires the estimating, matching and timing of revenue and expense. The accounting policies used conform to generally accepted accounting principles which have been consistently applied in the preparation of these financial statements. The financial statements and notes are representations of the Companys management which is responsible for their integrity and objectivity. Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud.  The Company's system of internal  accounting control is designed to assure, among other items, that  1) recorded  transactions  are valid;  2) valid  transactions  are recorded;  and  3) transactions  are  recorded in the proper  period in a timely  manner to produce financial  statements which present fairly the financial  condition,  results of operations  and cash  flows of the  Company  for the  respective  periods  being presented. Basis of Presentation: The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States. Principles of Consolidation: The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc.  All significant inter-company transactions have been eliminated.  All amounts are presented in U.S. Dollars unless otherwise stated. Development Stage Company:   The Company complies with ASC No. 915-10 for its characterization of the Company as development stage. Cash and Cash Equivalents: The Company considers all highly liquid debt instruments with a maturity of three months or less to be cash equivalents.  At times, cash balances may be in excess of the Federal Deposit Insurance Corporation (FDIC) insurance limits.  The carrying amount approximates fair market value. Fixed Assets: Fixed assets are carried at cost.  Depreciation is provided over each assets estimated useful life.  Upon retirement and disposal, the asset cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the determination of the net income.   Additions and significant improvements are capitalized and depreciated. Advertising Costs: The Company incurred no advertising costs for the years ended January 31, 2013 and 2012. Income Taxes: Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code.  Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration.  Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Use of Estimates: In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. Fair Value of Financial Instruments:   Pursuant to ASC No. 820, Fair Value Measurements and Disclosures, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of January 31, 2013.  The Companys financial instruments consist of cash, accounts payable, advances and notes payable.  The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.   Revenue Recognition:   Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned.  The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured.  For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (SAB 104)).   Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable. Earnings per Common Share: Earnings (loss) per share are calculated in accordance with ASC 260 Earnings per Share.   The weighted average number of common shares outstanding during each period is used to compute basic earnings (loss) per share.  Diluted earnings per share are computed using the weighted average number of shares and potentially dilutive common shares outstanding.   Dilutive potential common shares are additional common shares assumed to be exercised.     Potentially dilutive common shares consist of stock options and are excluded from the diluted earnings per share computation in periods where the Company has incurred a net loss, as their effect would be considered anti-dilutive. There were no potentially dilutive common stock equivalents as of January 31, 2013, therefore basic earnings per share equals diluted earnings per share for the year ended January 31, 2013.  The Company had 9,743,000 options outstanding at January 31, 2013. As the Company incurred a net loss during the year ended January 31, 2013, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive. Recently Issued Accounting Pronouncements: The Company  does not expect  the  adoption  of  recently  issued  accounting pronouncements  to have a significant  impact on the Companys  results of  operations, financial position or cash flows. falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).No definition available.false0Note 1 - Nature of Activities and Significant Accounting PoliciesfalseNote 1 - Nature of Activities and Significant Accounting PoliciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note1-NatureOfActivitiesAndSignificantAccountingPolicies12 XML 12 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (USD $)	3 Months Ended		49 Months Ended
Consolidated Statements of Operations (USD $)	Apr. 30, 2013	Apr. 30, 2012	Apr. 30, 2013
Income Statement [Abstract]
Revenue	$ 5,735	$ 2,045	$ 46,899
Cost of Sales	16,133	4,964	126,847
Gross Profit (Loss)	(10,398)	(2,919)	(79,948)
Operating Expenses:
Depreciation and Amortization	41,397	33,000	589,717
Selling and Marketing	12,608	1,774	97,029
General and Administrative	102,545	67,082	2,917,470
Total Operating Expenses	157,090	101,856	3,604,216
Net Operating Loss	(167,488)	(104,775)	(3,684,164)
Other Income (Expense):
Loss on Disposal of Assets	0	0	(4,087)
Loss on Recapitalization	0	0	(223,454)
Interest Expense	(18,797)	(16,149)	(357,299)
Total Other Income (Expense)	(18,797)	(16,149)	(584,840)
Net Loss	$ (186,285)	$ (120,924)	$ (4,269,004)
Weighted Average Shares Outstanding, Basic and Diluted	0.00	0.00
Basic and Diluted Earnings (Loss) per Share	$ 50,125,528	$ 43,350,112

XML 13 R10.htm IDEA: XBRL DOCUMENT

Note 5 - Employee Benefit Plans

3 Months Ended

Apr. 30, 2013

Compensation and Retirement Disclosure [Abstract]

Note 5 - Employee Benefit Plans

NOTE 4 - STOCKHOLDERS’ EQUITY

Preferred Stock:

The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share. There are no preferred shares outstanding at January 31, 2013 and 2012.

Common Stock:

The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share. These shares have full voting rights. At January 31, 2013 and 2012, there were 50,125,028 and 43,315,000 shares outstanding, respectively. No dividends were paid in the years ended January 31, 2013 or 2012.

Options and Warrants:

The Company had the following options or warrants outstanding at January 31, 2013:

Issued To	# Options	Dated	Expire	Strike Price
President and CEO	4,000,000	11/18/2010	11/18/2015	$0.25 per share
Vice President	2,000,000	11/18/2010	11/18/2015	$0.25 per share
Shareholder	127,500	08/28/2011	08/28/2016	$0.10 per share
Shareholder	50,000	04/04/2012	04/04/2013	$0.20 per share
Shareholder	8,000	04/27/2012	04/27/2013	$0.20 per share
Shareholder	127,500	04/29/2012	04/29/2017	$0.10 per share
Shareholder	200,000	05/17/2012	05/17/2013	$0.20 per share
Shareholder	50,000	05/22/2012	05/22/2013	$0.20 per share
Shareholder	80,000	05/21/2012	05/21/2013	$0.20 per share
Shareholder	25,000	07/12/2012	07/12/2013	$0.20 per share
Shareholder	25,000	07/10/2012	07/10/2013	$0.20 per share
Shareholder	50,000	08/09/2012	08/09/2013	$0.20 per share
Shareholder	1,000,000	08/31/2012	08/31/2016	$0.12 per share
Shareholder	2,000,000	01/18/2013	01/18/2018	$0.12 per share

XML 14 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 15 R9.xml IDEA: Note 4 - Stockholders' Equity 2.4.0.800000009 - Disclosure - Note 4 - Stockholders' Equitytruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_EquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Equity [Abstract]2false 2us-gaap_StockholdersEquityNoteDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 4 - STOCKHOLDERS EQUITY Preferred Stock: The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.  There are no preferred shares outstanding at January 31, 2013 and 2012. Common Stock: The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.  These shares have full voting rights.  At January 31, 2013 and 2012, there were 50,125,028 and 43,315,000 shares outstanding, respectively.  No dividends were paid in the years ended January 31, 2013 or 2012.   Options and Warrants: The Company had the following options or warrants outstanding at January 31, 2013:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 21%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Issued To</td> <td style="width: 16%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"># Options</td> <td style="width: 20%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Dated</td> <td style="width: 19%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Expire</td> <td style="width: 24%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Strike Price</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">President and CEO</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vice President</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2011</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2017</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">200,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">80,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2018</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> </table> falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Article 4 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section C Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(d),(e)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Preferred Stock -URI http://asc.fasb.org/extlink&oid=6521494 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph d -Article 4 Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656 false0Note 4 - Stockholders' EquityfalseNote 4 - Stockholders' EquityUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note4-StockholdersEquity12 XML 16 R12.xml IDEA: Note 7 - Commitments and Contingencies 2.4.0.800000012 - Disclosure - Note 7 - Commitments and Contingenciestruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_CommitmentsAndContingenciesDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Commitments and Contingencies Disclosure [Abstract]2false 2us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 7 COMMITMENTS AND CONTINGENCIES   The Company may from time to time be involved with various litigation and claims that arise in the normal course of business.  As of January 31, 2013, no such matters were outstanding. falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for commitments and contingencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 false0Note 7 - Commitments and ContingenciesfalseNote 7 - Commitments and ContingenciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note7-CommitmentsAndContingencies12 XML 17 R6.htm IDEA: XBRL DOCUMENT

Note 1 - Nature of Activities and Significant Accounting Policies

3 Months Ended

Apr. 30, 2013

Accounting Policies [Abstract]

Note 1 - Nature of Activities and Significant Accounting Policies

NOTE 1 – NATURE OF ACTIVITIES AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Activities, History and Organization – The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007. On December 16, 2009, an amendment was filed with the State of Nevada to change the name to “MedCareers Group, Inc.” (the “Company” or “MedCareers”) and change the authorized capital of the Company. On November 5, 2010, the Company issued 24,000,000 shares of its common stock in exchange for 100% of Nurses Lounge, Inc. (“Nurses Lounge”), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers. As a result, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers. The transaction was accounted for as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company. The share exchange was treated as a recapitalization of MedCareers. As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital. The Company operates a website for nurses, nursing schools and nurses organizations which enables the respective entities to communicate more easily and efficiently with their members.

Significant Accounting Policies:

Basis of Presentation:

The Company prepares its financial statements on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States.

Principles of Consolidation:

The financial statements include the accounts of MedCareers Group, Inc. as well as Nurses Lounge, Inc. All significant inter-company transactions have been eliminated. All amounts are presented in U.S. Dollars unless otherwise stated.

Development Stage Company:

The Company complies with ASC No. 915-10 for its characterization of the Company as development stage.

Cash and Cash Equivalents:

Fixed Assets:

Advertising Costs:

The Company incurred no advertising costs for the years ended January 31, 2013 and 2012.

Income Taxes:

Income from the corporation is taxed at regular corporate rates per the Internal Revenue Code. Although the Company has tax loss carry-forwards (see Note 7), there is uncertainty as to utilization prior to their expiration. Accordingly, the future income tax asset amounts have been fully reserved by a valuation allowance.

Use of Estimates:

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based.

Fair Value of Financial Instruments:

Pursuant to ASC No. 820, “Fair Value Measurements and Disclosures”, the Company is required to estimate the fair value of all financial instruments included on its balance sheet as of January 31, 2013. The Company’s financial instruments consist of cash, accounts payable, advances and notes payable. The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments.

Revenue Recognition:

Revenue from contracts for consulting services with fees based on time and materials or cost-plus are recognized as the services are performed and amounts are earned. The Company considers amounts to be earned once evidence of an arrangement has been obtained, services are delivered, fees are fixed or determinable, and collectability is reasonably assured. For contracts with fixed fees, the Company recognizes revenues as amounts become billable in accordance with contract terms, provided the billable amounts are not contingent, are consistent with the services delivered, and are earned. The Company recognizes revenue in accordance with ASC 605-10, "Revenue Recognition in Financial Statements", (formerly Staff Accounting Bulletin No. 104 (“SAB 104”)). Revenue is recognized when persuasive evidence of an arrangement exists, delivery or service has occurred, the sales price is fixed or determinable and receipt of payment is probable.

Earnings per Common Share:

There were no potentially dilutive common stock equivalents as of January 31, 2013, therefore basic earnings per share equals diluted earnings per share for the year ended January 31, 2013. The Company had 9,743,000 options outstanding at January 31, 2013. As the Company incurred a net loss during the year ended January 31, 2013, the basic and diluted loss per common share is the same amount, as any common stock equivalents would be considered anti-dilutive.

Recently Issued Accounting Pronouncements:

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Note 3 - Notes Payable

3 Months Ended

Apr. 30, 2013

Debt Disclosure [Abstract]

Note 3 - Notes Payable

NOTE 3 - NOTES PAYABLE

The components of the Company’s debt as of January 31, 2013 and 2012 were as follows:

	2013			2012
Note Payable - $100,000, 12% interest payable monthly or accrued, due Nov 4, 2013	$ 100,000		$	100,000
Note Payable - $190,000, 12% interest payable monthly or accrued, due Oct 29, 2013	288,150			240,000
Note Payable - $25,000, 12% interest payable monthly or accrued, due March 11, 2014	25,000			25,000
Note Payable - $25,000, 12% interest added to note quarterly, due April 30, 2013	25,000			25,000
Note Payable - $16,000, 12% interest added to note quarterly, due January 31, 2014	16,000			16,000
Note Payable - $70,000, 12% interest added to note quarterly, due February 4, 2013	70,000			70,000
Note Payable - $40,000, 12% interest added to note quarterly, due April 28, 2013	40,000			40,000
Note Payable - $4,000, 12% interest added to note quarterly, due April 30, 2013	4,000			4,000
Note Payable - $30,000, 12% interest added to note quarterly, due Nov 5, 2013	30,000			0
Note Payable - $5,000, 12% interest added to note quarterly, due Nov 5, 2013	5,000			0
Subtotal	603,150			520,000
Less – currently payable	(578,150)			(495,000)
Long-term debt	$	25,000		$	25,000

The Company had accrued $89,333 and $36,046 interest on the notes at January 31, 2013 and 2012, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

XML 19 R11.xml IDEA: Note 6 - Income Taxes 2.4.0.800000011 - Disclosure - Note 6 - Income Taxestruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_ScheduleOfInvestmentsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule of Investments [Abstract]2false 2us-gaap_FederalIncomeTaxNoteTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 6 INCOME TAXES   MedCareers Group, Inc. has incurred losses since inception.  Therefore, MedCareers has no federal tax liability.  Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes.  The net deferred tax asset generated by the loss carryforward has been fully reserved.  The cumulative net operating loss carryforward is about $4,755,621 at January 31, 2012 of which $3,810,987 is available for carryforward for federal income tax purposes and will expire in fiscal years 2026 to 2028.  At January 31, 2013 and 2012, the deferred tax asset consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td colspan="2" style="text-align: center">2013</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center">2012</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Deferred tax asset:</td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td nowrap="nowrap" style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td nowrap="nowrap" style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 59%; text-align: justify">   From Net operating loss</td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 2%; text-align: justify">$   </td> <td style="width: 15%; text-align: right"> 837,432</td> <td nowrap="nowrap" style="width: 1%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 3%; text-align: justify">$</td> <td style="width: 14%; text-align: justify"> 837,432</td> <td nowrap="nowrap" style="width: 4%; text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify">   Less valuation allowance</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(837,432</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: justify">)</td> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">(837,432</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: justify">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 3pt; text-align: justify">   Net deferred tax asset</td> <td style="padding-bottom: 3pt; text-align: justify"> </td> <td style="border-bottom: black 2.25pt double; text-align: justify">$</td> <td style="border-bottom: black 2.25pt double; text-align: justify">             0</td> <td nowrap="nowrap" style="padding-bottom: 3pt; text-align: justify"> </td> <td style="padding-bottom: 3pt; text-align: justify"> </td> <td style="border-bottom: black 2.25pt double; text-align: justify">$</td> <td style="border-bottom: black 2.25pt double; text-align: justify">            0</td> <td nowrap="nowrap" style="padding-bottom: 3pt; text-align: justify"> </td></tr> </table> falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the federal tax basis of investment holdings. This item captures the aggregate cost of securities, aggregate gross unrealized appreciation for all securities in which there is an excess of value over tax cost, aggregate gross unrealized depreciation for all securities in which there is an excess of tax cost over value, net unrealized appreciation (depreciation), and an explanation of the differences between tax and book.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 5 -Subparagraph (SX 210.12-13) -URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611282-123010 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12) -URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611133-123010 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 4 -Subparagraph (SX 210.12-12C) -URI http://asc.fasb.org/extlink&oid=6955306&loc=d3e611225-123010 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 13 -Article 12 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12C -Article 12 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Article 12 false0Note 6 - Income TaxesfalseNote 6 - Income TaxesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note6-IncomeTaxes12 XML 20 R11.htm IDEA: XBRL DOCUMENT

Note 6 - Income Taxes

3 Months Ended

Apr. 30, 2013

Schedule of Investments [Abstract]

Note 6 - Income Taxes

NOTE 6 – INCOME TAXES

MedCareers Group, Inc. has incurred losses since inception. Therefore, MedCareers has no federal tax liability. Additionally there are limitations imposed by certain transactions which are deemed to be ownership changes. The net deferred tax asset generated by the loss carryforward has been fully reserved. The cumulative net operating loss carryforward is about $4,755,621 at January 31, 2012 of which $3,810,987 is available for carryforward for federal income tax purposes and will expire in fiscal years 2026 to 2028. At January 31, 2013 and 2012, the deferred tax asset consisted of the following:

	2013			2012
Deferred tax asset:
From Net operating loss	$	837,432		$	837,432
Less valuation allowance		(837,432	)		(837,432	)
Net deferred tax asset	$	0		$	0

- Definition

Tabular disclosure of the federal tax basis of investment holdings. This item captures the aggregate cost of securities, aggregate gross unrealized appreciation for all securities in which there is an excess of value over tax cost, aggregate gross unrealized depreciation for all securities in which there is an excess of tax cost over value, net unrealized appreciation (depreciation), and an explanation of the differences between tax and book.

+ References+ Details

XML 21 R14.xml IDEA: Note 9 - Recent Accounting Pronouncements 2.4.0.800000014 - Disclosure - Note 9 - Recent Accounting Pronouncementstruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Organization, Consolidation and Presentation of Financial Statements [Abstract]2false 2us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 9 RECENT ACCOUNTING PRONOUNCEMENTS The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Companys results of operations, financial position or cash flows. falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.No definition available.false0Note 9 - Recent Accounting PronouncementsfalseNote 9 - Recent Accounting PronouncementsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note9-RecentAccountingPronouncements12 XML 22 R2.xml IDEA: Consolidated Balance Sheets 2.4.0.800000002 - Statement - Consolidated Balance Sheetstruefalsefalse1false USDfalsefalse$AsOf2013-04-30http://www.sec.gov/CIK0001438901instant2013-04-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$AsOf2013-01-31http://www.sec.gov/CIK0001438901instant2013-01-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_AssetsCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Current assets:2false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3071830718USD$falsetruefalse2truefalsefalse8968089680USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2Cash and cash equivalents3false 4us-gaap_OtherAssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse13851385falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.8) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 false2Other Current Assets4true 3us-gaap_AssetsNoncurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Property, Plant and Equipment:5false 4us-gaap_MachineryAndEquipmentGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse17991799falsefalsefalse2truefalsefalse17991799falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 4 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765 false2Equipment6false 4us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1799-1799falsefalsefalse2truefalsefalse-1799-1799falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.14) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 14 -Article 5 false2Less: Accumulated depreciation7false 4us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false2Total Fixed Assets8false 4us-gaap_DepositsAssetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5028050280falsefalsefalse2truefalsefalse9221792217falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false2Deferred Fees (net)9false 4us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse8238382383falsefalsefalse2truefalsefalse181897181897falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 false2TOTAL ASSETS10false 4us-gaap_AccountsPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1062510625falsefalsefalse2truefalsefalse69186918falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accounts Payable11false 4us-gaap_AccruedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse28382838falsefalsefalse2truefalsefalse1185211852falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accrued Expenses12false 4us-gaap_DueToRelatedPartiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse215424215424falsefalsefalse2truefalsefalse178143178143falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(k)(1)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph k -Subparagraph 1 -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accounts Payable - Related Parties13false 4us-gaap_InterestPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse106630106630falsefalsefalse2truefalsefalse8933389333falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765 false2Accrued Interest Payable14false 4us-gaap_NotesAndLoansPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse640650640650falsefalsefalse2truefalsefalse578150578150falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20 -Article 5 false2Current portion of notes payable15false 4us-gaap_LiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse976167976167falsefalsefalse2truefalsefalse864396864396falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 false2Total Current Liabilities16true 3us-gaap_LiabilitiesNoncurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Long Term Liabilities:17false 4us-gaap_CapitalLeaseObligationsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse640650640650falsefalsefalse2truefalsefalse603150603150falsefalsefalsexbrli:monetaryItemTypemonetaryAmount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 16 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 false2Notes Payable18false 4us-gaap_DebtCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse-640650-640650falsefalsefalse2truefalsefalse-578150-578150falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Article 5 false2Less: Current Potion19false 4us-gaap_LiabilitiesNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse2500025000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of obligation due after one year or beyond the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22, 23, 24, 25, 26, 27 -Article 5 false2Total Long Term Liabilities20false 4us-gaap_Liabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse976167976167falsefalsefalse2truefalsefalse889396889396falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Total Liabilities21false 4us-gaap_PreferredStockValueOutstandingus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryValue of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false2Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 1,000 and 1,000 shares issued and outstanding22false 4us-gaap_CommonStockValueOutstandingus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5012650126falsefalsefalse2truefalsefalse5012550125falsefalsefalsexbrli:monetaryItemTypemonetaryValue of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false2Common Stock, $0.001 par value, 350,000,000 shares authorized. 50125000 and 43,315,000 shares issued and outstanding23false 4us-gaap_AdditionalPaidInCapitalus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse39979963997996falsefalsefalse2truefalsefalse39979973997997falsefalsefalsexbrli:monetaryItemTypemonetaryExcess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Additional Paid In Capital24false 4us-gaap_RetainedEarningsAccumulatedDeficitus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-4941906-4941906falsefalsefalse2truefalsefalse-4755621-4755621falsefalsefalsexbrli:monetaryItemTypemonetaryThe cumulative amount of the reporting entity's undistributed earnings or deficit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accumulated Deficit25false 4us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-893784-893784falsefalsefalse2truefalsefalse-707499-707499falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4590271-111686 false2TOTAL STOCKHOLDERS' EQUITY (DEFICIT)26false 4us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse8238382383USD$falsetruefalse2truefalsefalse181897181897USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 true2TOTAL LIABILITIES AND STOCKHOLDERS' EQUITYfalseConsolidated Balance Sheets (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/BalanceSheets226 XML 23 R9.htm IDEA: XBRL DOCUMENT

Note 4 - Stockholders' Equity

3 Months Ended

Apr. 30, 2013

Equity [Abstract]

Note 4 - Stockholders' Equity

NOTE 4 - STOCKHOLDERS’ EQUITY

Preferred Stock:

The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share. There are no preferred shares outstanding at January 31, 2013 and 2012.

Common Stock:

Options and Warrants:

The Company had the following options or warrants outstanding at January 31, 2013:

Issued To	# Options	Dated	Expire	Strike Price
President and CEO	4,000,000	11/18/2010	11/18/2015	$0.25 per share
Vice President	2,000,000	11/18/2010	11/18/2015	$0.25 per share
Shareholder	127,500	08/28/2011	08/28/2016	$0.10 per share
Shareholder	50,000	04/04/2012	04/04/2013	$0.20 per share
Shareholder	8,000	04/27/2012	04/27/2013	$0.20 per share
Shareholder	127,500	04/29/2012	04/29/2017	$0.10 per share
Shareholder	200,000	05/17/2012	05/17/2013	$0.20 per share
Shareholder	50,000	05/22/2012	05/22/2013	$0.20 per share
Shareholder	80,000	05/21/2012	05/21/2013	$0.20 per share
Shareholder	25,000	07/12/2012	07/12/2013	$0.20 per share
Shareholder	25,000	07/10/2012	07/10/2013	$0.20 per share
Shareholder	50,000	08/09/2012	08/09/2013	$0.20 per share
Shareholder	1,000,000	08/31/2012	08/31/2016	$0.12 per share
Shareholder	2,000,000	01/18/2013	01/18/2018	$0.12 per share

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

XML 24 R10.xml IDEA: Note 5 - Employee Benefit Plans 2.4.0.800000010 - Disclosure - Note 5 - Employee Benefit Planstruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_CompensationAndRetirementDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Compensation and Retirement Disclosure [Abstract]2false 2us-gaap_CompensationAndEmployeeBenefitPlansTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00 NOTE 4 - STOCKHOLDERS EQUITY Preferred Stock: The Company is authorized to issue 10,000,000 shares of Preferred Stock, having a par value of $0.001 per share.  There are no preferred shares outstanding at January 31, 2013 and 2012. Common Stock: The Company is authorized to issue 350,000,000 common shares at a par value of $0.001 per share.  These shares have full voting rights.  At January 31, 2013 and 2012, there were 50,125,028 and 43,315,000 shares outstanding, respectively.  No dividends were paid in the years ended January 31, 2013 or 2012.   Options and Warrants: The Company had the following options or warrants outstanding at January 31, 2013:   <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 21%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Issued To</td> <td style="width: 16%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"># Options</td> <td style="width: 20%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Dated</td> <td style="width: 19%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Expire</td> <td style="width: 24%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Strike Price</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">President and CEO</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Vice President</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2010</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2015</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.25 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2011</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/28/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/04/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">8,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/27/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">127,500</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">04/29/2017</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.10 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">200,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/17/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/22/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">80,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">05/21/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/12/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">25,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">07/10/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/09/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.20 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">1,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2012</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">08/31/2016</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">Shareholder</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2,000,000</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2013</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/18/2018</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">$0.12 per share</td></tr> </table>  falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.No definition available.false0Note 5 - Employee Benefit PlansfalseNote 5 - Employee Benefit PlansUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note5-EmployeeBenefitPlans12 XML 25 R5.xml IDEA: Consolidated Statement of Cash Flows 2.4.0.800000005 - Statement - Consolidated Statement of Cash Flowstruefalsefalse1false USDfalsefalse$From2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-02-01to2012-04-30http://www.sec.gov/CIK0001438901duration2012-02-01T00:00:002012-04-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2009-04-01to2013-04-30http://www.sec.gov/CIK0001438901duration2009-04-01T00:00:002013-04-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0CASH FLOWS FROM OPERATING ACTIVITIES:2false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-186285-186285USD$falsetruefalse2truefalsefalse-120924-120924USD$falsetruefalse3truefalsefalse-4269004-4269004USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false2Net Loss3true 2us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Adjustments to reconcile net loss to net cash used (provided) by operating activiites4false 3us-gaap_Depreciationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse2582625826falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Depreciation of Property and Equipment5false 3us-gaap_AmortizationOfDeferredLoanOriginationFeesNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4193741937falsefalsefalse2truefalsefalse3300033000falsefalsefalse3truefalsefalse563890563890falsefalsefalsexbrli:monetaryItemTypemonetaryThe net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.1) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Direct Loan Origination Costs -URI http://asc.fasb.org/extlink&oid=6510860 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 30 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6378273&loc=d3e8446-111530 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 25 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6962437&loc=d3e7402-111529 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=27723605&loc=d3e8622-111531 false2Amortization of Deferred Fees6false 3us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse165000165000falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of expense reported during the period resulting from the transaction in which equity securities were issued to pay for goods or nonemployee services.No definition available.false2Shares Issued for Services7false 3MCGI_IssuanceOfCommonStockOptionsMCGI_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse1034710347falsefalsefalse3truefalsefalse19860171986017falsefalsefalsexbrli:monetaryItemTypemonetaryIssuance of Common Stock Options for goods or services.No definition available.false2Stock Option Expense8true 2us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Changes in assets and liabilities:9false 3us-gaap_IncreaseDecreaseInOtherCurrentAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-1385-1385falsefalsefalse2truefalsefalse-300-300falsefalsefalse3truefalsefalse-1365-1365falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.No definition available.false2(Increase) in Other Current Assets10false 3us-gaap_IncreaseDecreaseInAccountsPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse37073707falsefalsefalse2truefalsefalse-5652-5652falsefalsefalse3truefalsefalse1884518845falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Increase (Decrease) in Accounts Payable11false 3us-gaap_IncreaseDecreaseInAccruedLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2561425614falsefalsefalse2truefalsefalse2376723767falsefalsefalse3truefalsefalse117960117960falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Increase (Decrease) in Accrued Expenses12false 3us-gaap_IncreaseDecreaseInDueToRelatedPartiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1995019950falsefalsefalse2truefalsefalse4140041400falsefalsefalse3truefalsefalse198093198093falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Increase (Decrease) in Accrued Expenses - Realted Party13false 3us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-96462-96462falsefalsefalse2truefalsefalse-18362-18362falsefalsefalse3truefalsefalse-1134564-1134564falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 false2Net Cash Provided (Used) by Operating Activities14true 3us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0CASH FLOWS FROM INVESTING ACTIVITIES15false 4us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-215453-215453falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Purchase of Fixed Assets16false 4us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipmentus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse191026191026falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 false2Sale of Fixed Assets17false 4us-gaap_NetCashProvidedByUsedInInvestingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-24427-24427falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 false2Net Cash Provided (Used) by Investing Activities18true 3us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0CASH FLOWS FROM FINANCING ACTIVITIES19false 4us-gaap_ProceedsFromNotesPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3750037500falsefalsefalse2truefalsefalse50005000falsefalsefalse3truefalsefalse615650615650falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from a borrowing supported by a written promise to pay an obligation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false2Proceeds from Notes Payable20false 4us-gaap_ProceedsFromRepaymentsOfNotesPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse1250012500falsefalsefalse3truefalsefalse322000322000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 false2Payments on Notes Payable21false 4us-gaap_ProceedsFromIssuanceOfCommonStockus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse246670246670falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the additional capital contribution to the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false2Proceeds from Sale of Common Stock22false 4us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1us-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-185939-185939falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586 false2Debt Assumed in Acquisition23false 4us-gaap_RepaymentsOfAssumedDebtus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse209429209429falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow from the repayments of a long-term debt originally issued by another party but is assumed by the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 false2Debt Assumed by Buyer In Asset Sale24false 4us-gaap_IncreaseDecreaseInInterestPayableNetus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-35731-35731falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Interest Added to Notes Payable25false 4us-gaap_StockIssuedDuringPeriodValueAcquisitionsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse1600016000falsefalsefalsexbrli:monetaryItemTypemonetaryValue of stock issued pursuant to acquisitions during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 false2Common Stock Issued on Recapitalization26false 4us-gaap_NetCashProvidedByUsedInFinancingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3750037500falsefalsefalse2truefalsefalse1750017500falsefalsefalse3truefalsefalse11880791188079falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 false2Net Cash Provided by Financing Activities27false 4us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-58962-58962falsefalsefalse2truefalsefalse-862-862falsefalsefalse3truefalsefalse2908829088falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906 false2NET INCREASE (DECREASE) IN CASH AND CASH EQUAVILENTS28false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse8968089680falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD29false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse3071830718falsefalsefalse2truefalsefalse5050falsefalsefalse3truefalsefalse3071830718falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2CASH AND CASH EQUIVALENTS AT END OF PERIOD30true 4us-gaap_SupplementalCashFlowInformationAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0SUPPLEMENTAL DISCLOSURES31false 5us-gaap_InterestPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse5774057740falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of cash paid for interest during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 false2Cash Paid During the Year for Interest Expense32false 5us-gaap_IncomeTaxesPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 false2Cash Paid During the Year for Taxes33false 5MCGI_IssuanceOfCommonStockForServicesMCGI_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse165000165000falsefalsefalsexbrli:monetaryItemTypemonetaryIssuance of Common Stock for Services PerformedNo definition available.false2Issuance of Common Shares for Services34false 5us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse884741884741falsefalsefalsexbrli:monetaryItemTypemonetaryThe net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.No definition available.false2Issuance of Common Stock for Debt35false 5us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefitus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00USD$falsetruefalse2truefalsefalse00USD$falsetruefalse3truefalsefalse614170614170USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe amount of income tax expense reduction and deferred tax asset recorded in the transaction in which equity securities were issued to pay for goods or nonemployee services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 false2Issuance of Common Stock for FeesfalseConsolidated Statement of Cash Flows (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/StatementOfCashFlows335 EXCEL 26 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Y9#%E.&9E85]F8C5A7S1F9&1?.60W9%\S.&$S M9C4W9F9F-F$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO M=&5?-%]3=&]C:VAO;&1E#I%>&-E;%=O65E7T)E;F5F:71?4&QA M;G,\+W@Z3F%M93X-"B`@("`\>#I7;W)K&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T* M("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!) M;F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^2F%N(#,Q+`T* M"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^9F%L2!A(%=E;&PM:VYO=VX@4V5A'0^3F\\2!A(%9O;'5N=&%R M>2!&:6QE'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!# M;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M43$\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Y9#%E.&9E85]F8C5A7S1F9&1?.60W9%\S.&$S M9C4W9F9F-F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.60Q93AF M96%?9F(U85\T9F1D7SED-V1?,SAA,V8U-V9F9C9A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F5D+"`Q+#`P,"!A;F0@,2PP,#`@F5D+B`U,#$R-3`P,"!A;F0@ M-#,L,S$U+#`P,"!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N9&EN9SPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y9#%E.&9E M85]F8C5A7S1F9&1?.60W9%\S.&$S9C4W9F9F-F$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO.60Q93AF96%?9F(U85\T9F1D7SED-V1?,SAA,V8U M-V9F9C9A+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-EF%T:6]N M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'!E M;G-E2!/<&5R871I;F<@06-T:79I=&EE'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!);G9E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'`@'0M86QI9VXZ(&IU2!W87,@9F]R;65D M(&%S(%)8(%-C2X@3VX@3F]V96UB97(@-2P@,C`Q,"P@=&AE($-O;7!A;GD@:7-S=65D M(#(T+#`P,"PP,#`-"G-H87)E&%S(&-O2!O9B!T:&4@=F]T:6YG('-T M;V-K(&]F($UE9$-A&-H86YG92!W87,@=')E871E9"!A7,@8F5E;B!T:&4@F5D(&ET2!W:71H('1H96ER(&UE;6)E28C,30V.W,@;6%N M86=E;65N=`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`P.R!M87)G:6XM;&5F=#H@,"<^/'4^0F%S:7,@;V8@ M4')E6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(&IU2!A8V-E M<'1E9"!I;B!T:&4-"E5N:71E9"!3=&%T97,N/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3L@;6%R9VEN+7)I M9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^5&AE(&9I;F%N8VEA;"!S=&%T96UE M;G1S#0II;F-L=61E('1H92!A8V-O=6YT'0M M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(&IU3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G M:6XM;&5F=#H@,"<^5&AE($-O;7!A;GD@8V]N2!O9B!T M:')E92!M;VYT:',@;W(@;&5S3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^1FEX960@ M87-S971S(&%R92!C87)R:65D#0IA="!C;W-T+B8C,38P.R8C,38P.T1E<')E M8VEA=&EO;B!I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU3L@;6%R9VEN+7)I9VAT.B`P.R!M M87)G:6XM;&5F=#H@,"<^26YC;VUE(&9R;VT@=&AE(&-OF%T:6]N('!R:6]R M('1O('1H96ER(&5X<&ER871I;VXN)B,Q-C`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`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!A2!R96-O9VYI>F5S(')E=F5N=64@:6X-"F%C8V]R M9&%N8V4@=VET:"!!4T,@-C`U+3$P+"`F(S,T.SQI/E)E=F5N=64@4F5C;V=N M:71I;VX@:6X@1FEN86YC:6%L(%-T871E;65N=',\+VD^)B,S-#LL("AF;W)M M97)L>2!3=&%F9B!!8V-O=6YT:6YG($)U;&QE=&EN#0I.;RX@,3`T("@F(S$T M-SM304(@,3`T)B,Q-#@[*2DN)B,Q-C`[)B,Q-C`[)B,Q-C`[4F5V96YU92!I MF5D('=H96X@<&5R&ES=',L(&1E;&EV97)Y#0IO&5D(&]R(&1E=&5R;6EN M86)L92!A;F0@3L@;6%R9VEN+7)I9VAT M.B`P.R!M87)G:6XM;&5F=#H@,"<^/'4^16%R;FEN9W,@<&5R($-O;6UO;@T* M4VAA3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^16%R;FEN9W,@ M*&QO&5R8VES960N)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[4&]T96YT:6%L;'D@9&EL=71I M=F4-"F-O;6UO;B!S:&%R97,@8V]N0T*:&%S(&EN8W5R2`S M,2P@,C`Q,RP@=&AE65A M2!H M860@.2PW-#,L,#`P(&]P=&EO;G,@;W5T2`S M,2P@,C`Q,RX@07,@=&AE($-O;7!A;GD@:6YC=7)R960-"F$@;F5T(&QO2!)7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&IU M'1E;F0@;F]T97,@<&%Y86)L92X@4W1O8VL@:7-S=65D('=A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@8V]L6QE/3-$ M)V9O;G0M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)W9EF4Z(#$P<'0G/D1E9F5R'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O M;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#$P<'0G/DQE6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B@Q.3`L,S8W*3PO9F]N M=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)W9EF4Z(#$P<'0G/D1E9F5R'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$ M)VUA3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\Y9#%E.&9E85]F8C5A7S1F9&1?.60W9%\S.&$S9C4W M9F9F-F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.60Q93AF96%? M9F(U85\T9F1D7SED-V1?,SAA,V8U-V9F9C9A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M6%B;&4\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@ M("`@/'1H(&-L87-S/3-$=&@@8V]L'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0O,3(P)2!4 M:6UE28C,30V.W,-"F1E8G0@87,@;V8@/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/DYO=&4@4&%Y86)L92`M M("0Q,#`L,#`P+"`Q,B4@:6YT97)E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/DYO=&4@4&%Y86)L92`M("0Q.3`L,#`P+"`Q,B4@:6YT97)E'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/C(X."PQ-3`\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N M/3-$,B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG M+71O<#H@,2XU<'0[('!A9&1I;F6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M M6QE M/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(U+#`P,#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P)SXF(S$V M,#L\+W1D/CPO='(^#0H\='(^#0H@("`@/'1D('-T>6QE/3-$)W9E6%B M;&4@+2`D,C4L,#`P+"`Q,B4@:6YT97)E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG.B`Q+C5P=#L@=&5X M="UA;&EG;CH@6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/C$V+#`P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@'0M86QI9VXZ(&IU'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/DYO=&4@4&%Y86)L92`M M("0W,"PP,#`L(#$R)2!I;G1E2P@9'5E($9E8G)U87)Y(#0L(#(P,3,\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M8V]L'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$ M,B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+71O M<#H@,2XU<'0[('!A9&1I;F6QE/3-$)V9O M;G0M6QE/3-$)W9E2<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@=&]P.R!P861D:6YG.B`Q+C5P=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C0P+#`P,#PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+71O<#H@ M,2XU<'0[('!A9&1I;F6QE/3-$)V9O;G0M M6QE M/3-$)W9E2<^)B,Q-C`[/"]T9#X\ M+W1R/@T*/'1R/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!P861D:6YG.B`Q+C5P=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C0L,#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M2<^)B,Q-C`[/"]T9#X\+W1R/@T* M/'1R/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!P M861D:6YG.B`Q+C5P=#L@=&5X="UA;&EG;CH@6QE M/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/C,P+#`P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+71O<#H@,2XU<'0[('!A9&1I M;F6QE/3-$)V9O;G0M'0M M86QI9VXZ(&IU'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/DYO=&4@4&%Y86)L92`M("0U+#`P,"P@,3(E(&EN=&5R97-T M(&%D9&5D('1O(&YO=&4@<75A6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)W9EF4Z(#$P<'0G M/E-U8G1O=&%L/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C4R,"PP,#`\+V9O;G0^/"]T M9#X-"B`@("`\=&0@6QE/3-$)W9E'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O M;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W=I9'1H.B`W)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(&IU2!H860@86-C6QE M/3-$)VUA3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\Y9#%E.&9E85]F8C5A7S1F9&1?.60W9%\S.&$S M9C4W9F9F-F$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.60Q93AF M96%?9F(U85\T9F1D7SED-V1?,SAA,V8U-V9F9C9A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6QE/3-$)VUA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU2!IF5D#0IT;R!I2`S,2P@,C`Q,R!A;F0@,C`Q,BX\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU2!IF5D#0IT M;R!I0T*,S$L M(#(P,3,@86YD(#(P,3(L('1H97)E('=E2XF(S$V M,#L@3F\@9&EV:61E;F1S('=E65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/'4^3W!T:6]N2!H860@=&AE(&9O;&QO=VEN9R!O M<'1I;VYS(&]R('=A6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T($-A;&EB6QE/3-$)W=I9'1H.B`R,24[(&)O'0@,7!T('-O;&ED.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL M969T.B`U+C1P="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q-B4[(&)O'0@,7!T('-O;&ED.R!P861D:6YG+7)I9VAT.B`U+C1P=#L@ M<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`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`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`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^ M/'4^4')E9F5R6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&IU3L@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^/'4^ M0V]M;6]N(%-T;V-K.CPO=3X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(&IU2`S,2P@,C`Q,R!O M6QE/3-$)W=I9'1H.B`R,"4[(&)O'0@,7!T('-O;&ED.R!P861D:6YG+7)I9VAT M.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@8V5N M=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R-"4[ M(&)O'0@,7!T('-O;&ED.R!P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG M;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT.B`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xml IDEA: Consolidated Statements of Operations 2.4.0.800000004 - Statement - Consolidated Statements of Operationstruefalsefalse1false USDfalsefalse$From2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$From2012-02-01to2012-04-30http://www.sec.gov/CIK0001438901duration2012-02-01T00:00:002012-04-30T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$From2009-04-01to2013-04-30http://www.sec.gov/CIK0001438901duration2009-04-01T00:00:002013-04-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeStatementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Income Statement [Abstract]2false 2us-gaap_Revenuesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse57355735USD$falsetruefalse2truefalsefalse20452045USD$falsetruefalse3truefalsefalse4689946899USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Revenue3false 2us-gaap_CostOfGoodsSoldus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1613316133falsefalsefalse2truefalsefalse49644964falsefalsefalse3truefalsefalse126847126847falsefalsefalsexbrli:monetaryItemTypemonetaryTotal costs related to goods produced and sold during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2Cost of Sales4false 2us-gaap_GrossProfitus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-10398-10398falsefalsefalse2truefalsefalse-2919-2919falsefalsefalse3truefalsefalse-79948-79948falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2Gross Profit (Loss)5true 2us-gaap_OperatingExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Operating Expenses:6false 3us-gaap_DepreciationAndAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse4139741397falsefalsefalse2truefalsefalse3300033000falsefalsefalse3truefalsefalse589717589717falsefalsefalsexbrli:monetaryItemTypemonetaryThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Depreciation and Amortization7false 3us-gaap_SellingAndMarketingExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1260812608falsefalsefalse2truefalsefalse17741774falsefalsefalse3truefalsefalse9702997029falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total amount of expenses directly related to the marketing or selling of products or services.No definition available.false2Selling and Marketing8false 3us-gaap_GeneralAndAdministrativeExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse102545102545falsefalsefalse2truefalsefalse6708267082falsefalsefalse3truefalsefalse29174702917470falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2General and Administrative9false 3us-gaap_OperatingExpensesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse157090157090falsefalsefalse2truefalsefalse101856101856falsefalsefalse3truefalsefalse36042163604216falsefalsefalsexbrli:monetaryItemTypemonetaryGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.No definition available.false2Total Operating Expenses10false 3us-gaap_OperatingIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-167488-167488falsefalsefalse2truefalsefalse-104775-104775falsefalsefalse3truefalsefalse-3684164-3684164falsefalsefalsexbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No definition available.false2Net Operating Loss11true 3us-gaap_OtherIncomeAndExpensesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Other Income (Expense):12false 4us-gaap_OtherExpensesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-4087-4087falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents a sum total of expenses not separately reflected on the income statement for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 7 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.7) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4,6) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2Loss on Disposal of Assets13false 4us-gaap_OtherGeneralExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse-223454-223454falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of general expenses not normally included in Other Operating Costs and Expenses.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.6) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 6 -Article 5 false2Loss on Recapitalization14false 4us-gaap_InterestExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-18797-18797falsefalsefalse2truefalsefalse-16149-16149falsefalsefalse3truefalsefalse-357299-357299falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of the cost of borrowed funds accounted for as interest expense.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 false2Interest Expense15false 2us-gaap_OtherIncomeus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-18797-18797falsefalsefalse2truefalsefalse-16149-16149falsefalsefalse3truefalsefalse-584840-584840falsefalsefalsexbrli:monetaryItemTypemonetaryReflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.4) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 4 -Article 7 false2Total Other Income (Expense)16false 2us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-186285-186285USD$falsetruefalse2truefalsefalse-120924-120924USD$falsetruefalse3truefalsefalse-4269004-4269004USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false2Net Loss17false 2us-gaap_WeightedAverageNumberOfSharesIssuedBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.000.00falsefalsefalse2truefalsefalse0.000.00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThis element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e2646-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 false1Weighted Average Shares Outstanding, Basic and Diluted18false 2us-gaap_EarningsPerShareBasicAndDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5012552850125528USD$falsetruefalse2truefalsefalse4335011243350112USD$falsetruefalse3falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalThe amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.No definition available.false3Basic and Diluted Earnings (Loss) per SharefalseConsolidated Statements of Operations (USD $)NoRoundingNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/StatementsOfOperations318 XML 28 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 HtmlAndXml 7 94 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://nurseslounge.com/role/DocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://nurseslounge.com/role/BalanceSheets Consolidated Balance Sheets R2.xml false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://nurseslounge.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) R3.xml false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://nurseslounge.com/role/StatementsOfOperations Consolidated Statements of Operations R4.xml false false R5.htm 00000005 - Statement - Consolidated Statement of Cash Flows Sheet http://nurseslounge.com/role/StatementOfCashFlows Consolidated Statement of Cash Flows R5.xml false false R6.htm 00000006 - Disclosure - Note 1 - Nature of Activities and Significant Accounting Policies Sheet http://nurseslounge.com/role/Note1-NatureOfActivitiesAndSignificantAccountingPolicies Note 1 - Nature of Activities and Significant Accounting Policies R6.xml false false R7.htm 00000007 - Disclosure - Note 2 - Deferred Fees Sheet http://nurseslounge.com/role/Note2-DeferredFees Note 2 - Deferred Fees R7.xml false false R8.htm 00000008 - Disclosure - Note 3 - Notes Payable Notes http://nurseslounge.com/role/Note3-NotesPayable Note 3 - Notes Payable R8.xml false false R9.htm 00000009 - Disclosure - Note 4 - Stockholders' Equity Sheet http://nurseslounge.com/role/Note4-StockholdersEquity Note 4 - Stockholders' Equity R9.xml false false R10.htm 00000010 - Disclosure - Note 5 - Employee Benefit Plans Sheet http://nurseslounge.com/role/Note5-EmployeeBenefitPlans Note 5 - Employee Benefit Plans R10.xml false false R11.htm 00000011 - Disclosure - Note 6 - Income Taxes Sheet http://nurseslounge.com/role/Note6-IncomeTaxes Note 6 - Income Taxes R11.xml false false R12.htm 00000012 - Disclosure - Note 7 - Commitments and Contingencies Sheet http://nurseslounge.com/role/Note7-CommitmentsAndContingencies Note 7 - Commitments and Contingencies R12.xml false false R13.htm 00000013 - Disclosure - Note 8 - Going Concern and Financial Position Sheet http://nurseslounge.com/role/Note8-GoingConcernAndFinancialPosition Note 8 - Going Concern and Financial Position R13.xml false false R14.htm 00000014 - Disclosure - Note 9 - Recent Accounting Pronouncements Sheet http://nurseslounge.com/role/Note9-RecentAccountingPronouncements Note 9 - Recent Accounting Pronouncements R14.xml false false R15.htm 00000015 - Disclosure - Note 10 - Loss on Recapitalization Sheet http://nurseslounge.com/role/Note10-LossOnRecapitalization Note 10 - Loss on Recapitalization R15.xml false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Apr. 30, 2012' Process Flow-Through: 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00000004 - Statement - Consolidated Statements of Operations Process Flow-Through: 00000005 - Statement - Consolidated Statement of Cash Flows mcgi-20130131.xml mcgi-20130131.xsd mcgi-20130131_cal.xml mcgi-20130131_def.xml mcgi-20130131_lab.xml mcgi-20130131_pre.xml true true XML 29 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) (USD $)	Apr. 30, 2013	Jan. 31, 2013
Statement of Financial Position [Abstract]
Preferred stock, par or stated value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	350,000,000	350,000,000
Common stock, shares outstanding	50,126,000	50,125,000

XML 30 R14.htm IDEA: XBRL DOCUMENT

Note 9 - Recent Accounting Pronouncements

3 Months Ended

Apr. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Note 9 - Recent Accounting Pronouncements

NOTE 9 – RECENT ACCOUNTING PRONOUNCEMENTS

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.

XML 31 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statement of Cash Flows (USD $)	3 Months Ended		49 Months Ended
Consolidated Statement of Cash Flows (USD $)	Apr. 30, 2013	Apr. 30, 2012	Apr. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (186,285)	$ (120,924)	$ (4,269,004)
Adjustments to reconcile net loss to net cash used (provided) by operating activiites
Depreciation of Property and Equipment	0	0	25,826
Amortization of Deferred Fees	41,937	33,000	563,890
Shares Issued for Services	0	0	165,000
Stock Option Expense	0	10,347	1,986,017
Changes in assets and liabilities:
(Increase) in Other Current Assets	(1,385)	(300)	(1,365)
Increase (Decrease) in Accounts Payable	3,707	(5,652)	18,845
Increase (Decrease) in Accrued Expenses	25,614	23,767	117,960
Increase (Decrease) in Accrued Expenses - Realted Party	19,950	41,400	198,093
Net Cash Provided (Used) by Operating Activities	(96,462)	(18,362)	(1,134,564)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Fixed Assets	0	0	(215,453)
Sale of Fixed Assets	0	0	191,026
Net Cash Provided (Used) by Investing Activities	0	0	(24,427)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Notes Payable	37,500	5,000	615,650
Payments on Notes Payable	0	12,500	322,000
Proceeds from Sale of Common Stock	0	0	246,670
Debt Assumed in Acquisition	0	0	(185,939)
Debt Assumed by Buyer In Asset Sale	0	0	209,429
Interest Added to Notes Payable	0	0	(35,731)
Common Stock Issued on Recapitalization	0	0	16,000
Net Cash Provided by Financing Activities	37,500	17,500	1,188,079
NET INCREASE (DECREASE) IN CASH AND CASH EQUAVILENTS	(58,962)	(862)	29,088
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	89,680
CASH AND CASH EQUIVALENTS AT END OF PERIOD	30,718	50	30,718
SUPPLEMENTAL DISCLOSURES
Cash Paid During the Year for Interest Expense	0	0	57,740
Cash Paid During the Year for Taxes	0	0	0
Issuance of Common Shares for Services	0	0	165,000
Issuance of Common Stock for Debt	0	0	884,741
Issuance of Common Stock for Fees	$ 0	$ 0	$ 614,170

XML 32 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (USD $)	Apr. 30, 2013	Jan. 31, 2013
Current assets:
Cash and cash equivalents	$ 30,718	$ 89,680
Other Current Assets	1,385	0
Property, Plant and Equipment:
Equipment	1,799	1,799
Less: Accumulated depreciation	(1,799)	(1,799)
Total Fixed Assets	0	0
Deferred Fees (net)	50,280	92,217
TOTAL ASSETS	82,383	181,897
Accounts Payable	10,625	6,918
Accrued Expenses	2,838	11,852
Accounts Payable - Related Parties	215,424	178,143
Accrued Interest Payable	106,630	89,333
Current portion of notes payable	640,650	578,150
Total Current Liabilities	976,167	864,396
Long Term Liabilities:
Notes Payable	640,650	603,150
Less: Current Potion	(640,650)	(578,150)
Total Long Term Liabilities	0	25,000
Total Liabilities	976,167	889,396
Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 1,000 and 1,000 shares issued and outstanding	0	0
Common Stock, $0.001 par value, 350,000,000 shares authorized. 50125000 and 43,315,000 shares issued and outstanding	50,126	50,125
Additional Paid In Capital	3,997,996	3,997,997
Accumulated Deficit	(4,941,906)	(4,755,621)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(893,784)	(707,499)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 82,383	$ 181,897

XML 33 R7.xml IDEA: Note 2 - Deferred Fees 2.4.0.800000007 - Disclosure - Note 2 - Deferred Feestruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Accounting Policies [Abstract]2false 2us-gaap_DeferredChargesPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 2 DEFERRED FEES   Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at January 31, 2013 and 2012 were as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding: 1.5pt; text-align: justify"> </td> <td colspan="3" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2013</td> <td style="padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">2012</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Deferred Fees</td> <td style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">614,170</td> <td style="vertical-align: bottom; border-top: black 1pt solid"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">304,200</td></tr> <tr> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Less: Accumulated Amortization</td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(521,953</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid">)</td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: black 1pt solid; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">(190,367)</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; padding: 1.5pt; text-align: justify">Deferred Fees - Net</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">92,217</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double"> </td> <td style="vertical-align: bottom; padding: 1.5pt; text-align: right"> </td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; text-align: right">$</td> <td style="vertical-align: bottom; border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-top: 1.5pt; padding-bottom: 1.5pt; text-align: right">113,833</td></tr> </table> falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for deferral and amortization of significant deferred charges.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false0Note 2 - Deferred FeesfalseNote 2 - Deferred FeesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note2-DeferredFees12 XML 34 R3.xml IDEA: Consolidated Balance Sheets (Parenthetical) 2.4.0.800000003 - Statement - Consolidated Balance Sheets (Parenthetical)truefalsefalse1false USDfalsefalse$AsOf2013-04-30http://www.sec.gov/CIK0001438901instant2013-04-30T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false USDfalsefalse$AsOf2013-01-31http://www.sec.gov/CIK0001438901instant2013-01-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDPSharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1true 1us-gaap_StatementOfFinancialPositionAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Statement of Financial Position [Abstract]2false 2us-gaap_PreferredStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false3Preferred stock, par or stated value3false 2us-gaap_PreferredStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse1000000010000000falsefalsefalse2truefalsefalse1000000010000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares authorized4false 2us-gaap_PreferredStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesAggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares outstanding5false 2us-gaap_CommonStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of common stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false3Common stock, par value6false 2us-gaap_CommonStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse350000000350000000falsefalsefalse2truefalsefalse350000000350000000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares authorized7false 2us-gaap_CommonStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5012600050126000falsefalsefalse2truefalsefalse5012500050125000falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares outstandingfalseConsolidated Balance Sheets (Parenthetical) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/BalanceSheetsParenthetical27 XML 35 R13.htm IDEA: XBRL DOCUMENT

Note 8 - Going Concern and Financial Position

3 Months Ended

Apr. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Note 8 - Going Concern and Financial Position

NOTE 8 - GOING CONCERN AND FINANCIAL POSITION

MedCareers’ financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred cumulative losses through January 31, 2013 of $4,755,621 and has a working capital deficit at January 31, 2013 of $774,716.

- Definition

Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.

+ References+ Details

XML 36 R12.htm IDEA: XBRL DOCUMENT

Note 7 - Commitments and Contingencies

3 Months Ended

Apr. 30, 2013

Commitments and Contingencies Disclosure [Abstract]

Note 7 - Commitments and Contingencies

NOTE 7 – COMMITMENTS AND CONTINGENCIES

The Company may from time to time be involved with various litigation and claims that arise in the normal course of business. As of January 31, 2013, no such matters were outstanding.

- Definition

The entire disclosure for commitments and contingencies.

+ References+ Details

XML 37 R7.htm IDEA: XBRL DOCUMENT

Note 2 - Deferred Fees

3 Months Ended

Apr. 30, 2013

Accounting Policies [Abstract]

Note 2 - Deferred Fees

NOTE 2 – DEFERRED FEES

Deferred fees represent stock issued as fees to make or extend notes payable. Stock issued was valued at the date of issue and amortized over the term of the loan. Deferred fees at January 31, 2013 and 2012 were as follows:

	2013			2012
Deferred Fees	$	614,170		$	304,200
Less: Accumulated Amortization	(521,953		)	(190,367)
Deferred Fees - Net	$	92,217		$	113,833

XML 38 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 39 R13.xml IDEA: Note 8 - Going Concern and Financial Position 2.4.0.800000013 - Disclosure - Note 8 - Going Concern and Financial Positiontruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Organization, Consolidation and Presentation of Financial Statements [Abstract]2false 2us-gaap_LiquidityDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00  NOTE 8 - GOING CONCERN AND FINANCIAL POSITION   MedCareers financial statements are prepared using United States generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.  The Company has incurred cumulative losses through January 31, 2013 of $4,755,621 and has a working capital deficit at January 31, 2013 of $774,716.   Historically, revenues have not been sufficient to cover operating costs that would permit the Company to continue as a going concern.  The potential proceeds from the sale of common stock and other contemplated debt and equity financing, and increases in operating revenues from new development and business acquisitions might enable MedCareers to continue as a going concern.  There can be no assurance that the Company can or will be able to complete any debt or equity financing, or develop or acquire one or more business interests on terms favorable to it.  MedCareers financial statements do not include any adjustments that might result from the outcome of this uncertainty. falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.No definition available.false0Note 8 - Going Concern and Financial PositionfalseNote 8 - Going Concern and Financial PositionUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note8-GoingConcernAndFinancialPosition12 XML 40 R15.htm IDEA: XBRL DOCUMENT

Note 10 - Loss on Recapitalization

3 Months Ended

Apr. 30, 2013

Business Combinations [Abstract]

Note 10 - Loss on Recapitalization

NOTE 10 – LOSS ON RECAPITALIZATION

On November 5, 2010, the Company effected a recapitalization by issuing 24,000,000 shares of its Common Stock in exchange for 100% of Nurses Lounge, Inc. (“Nurses Lounge”), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers. Additionally, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers. The transaction was regarded as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company. The share exchange was treated as a recapitalization of MedCareers. As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital The loss on recapitalization of $223,454 represents the adjustment relating to the value recorded in the equity section of MedCareers pre-recapitalization and the value assigned to it upon recapitalization.

XML 41 R15.xml IDEA: Note 10 - Loss on Recapitalization 2.4.0.800000015 - Disclosure - Note 10 - Loss on Recapitalizationtruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:001true 1us-gaap_BusinessCombinationsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Combinations [Abstract]2false 2us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00 NOTE 10 LOSS ON RECAPITALIZATION   On November 5, 2010, the Company effected a recapitalization by issuing 24,000,000 shares of its Common Stock in exchange for 100% of Nurses Lounge, Inc. (Nurses Lounge), a Texas corporation. As a result of the share exchange, Nurses Lounge became the wholly-owned subsidiary of MedCareers. Additionally, the shareholders of Nurses Lounge owned a majority of the voting stock of MedCareers.  The transaction was regarded as a reverse merger whereby Nurses Lounge was considered to be the accounting acquirer as its shareholders retained control of MedCareers after the exchange, although MedCareers is the legal parent company.  The share exchange was treated as a recapitalization of MedCareers.  As such, Nurses Lounge (and its historical financial statements) is the continuing entity for financial reporting purposes. The financial statements have been prepared as if MedCareers had always been the reporting company and, on the share exchange date, changed its name and reorganized its capital  The loss on recapitalization of $223,454 represents the adjustment relating to the value recorded in the equity section of MedCareers pre-recapitalization and the value assigned to it upon recapitalization.  falsefalsefalsenonnum:textBlockItemTypenaThe entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.No definition available.false0Note 10 - Loss on RecapitalizationfalseNote 10 - Loss on RecapitalizationUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/Note10-LossOnRecapitalization12 XML 42 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information (USD $)	3 Months Ended
Document and Entity Information (USD $)	Apr. 30, 2013	Sep. 05, 2013
Document And Entity Information
Entity Registrant Name	MEDCAREERS GROUP, Inc.
Entity Central Index Key	0001438901
Document Type	10-Q
Document Period End Date	Jan. 31, 2013
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	No
Entity Filer Category	Smaller Reporting Company
Entity Public Float		$ 52,708,863
Entity Common Stock, Shares Outstanding		52,708,863
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2013

ZIP 43 0001121781-13-000366-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001121781-13-000366-xbrl.zip M4$L#!!0````(`#2+.$.MH4CK&R\``"7+`0`1`!P`;6-G:2TR,#$S,#$S,2YX M;6Q55`D``U,#0E)3`T)2=7@+``$$)0X```0Y`0``W#UK<]NVEM]W9O\#UG=N M-YF1;#W\DIWTCBK;66T3Q[6=;O+W>\W]QAX3<:!"&8_>[WVYJW?O>OW^'OO7 MC__^;PS^>?*C.V36?B#/V0<0BX:E*SMFO/,KPB;J2 MD4A83TVFD4@%O#"0SEA[_YBS>GV#97\5<:B2+[?]?-EQFD[/#@YFL]E^K![X M3"5?]7Z@-EON3F5)(/*U/O4^]-EO/]U^9,W&+ZP[363$6HUF>_]Q"'1<\!3& MX/=_MBX:'?BC=7C?:IXU.V='S0WAI3S-=`ZO\=BP_YCI[QX'223/\$\&6Q'K MLT;!;Y\^W@5C,>%U&>N4QX'8<[,B&7^MFM?L=#H' M]-8-71J)P!V,]@&^'G!=K(P(/C%^"1-X&Z;Y!'_PT8%Y61HJ*X<>FZ'2#0W% MPC@M@OV1>CB`%P>X0?5&L]YNNN&)&*Y$^?@`WKJ!4JO#5O/D*?K,"#)BH2NG$-O*B:A8.83XBS10D+^G)2KG'CMP2QF)#%2< MBL>4R?#]WE6B)@;#%B"9*O/YL-YN./CY-!&G,IWG3_/G,L0W0PG6@+`4)8Z[ MS>SU?][[$72C>=@^[32:[PX6)Q?@#BKA66A3D4@5+F,!DIJDJ-0_%N2XE8IW M2]/``GF3D.X"?%B:XIZ7$'`/+4M7\[FK/P\-C$Z]Z^?S8!'' MJE4]H!*$?"HWX?Q7QC MR+X"KES-!P?I*&Q1G-Y#K+\QE&:C_HM9WY]>M>P-Z>"E,6,;K^_K^,K5?'!= M>!OBB*N(CS8&,^21%@9":0%_Y5Z6)/A8ZH!'_RMX\EQ:ZCXAJU9;%H#_$5'T M$MS"*A7B;?AP M*Z8J264\,D60+:%5+[8,E)#I`;='*MEYW.6HC_& M"F$)[D+RRM#BT@OKK%@H`@G,UN_W^M=7>S\>M4X:IZ?'[=)6/P%L&;6;;!#) MX"I2/-T,$W3_'AJ-:B2\91U,6]LYZW$][L8A_G7Y?YE\X!&P4'?3'D^2.>!( M1;X5N-`./(5+NW'2/'UW\"Q8KX9@:P,$CQI_%79Y;>P)[$X[QZVF-D\ZG0*IU>N_&).U_-D6DVX`EB*+P/B%%V*:P)(\ ME2J&SY'`#[!`=X*F\P]Z?I,H",Q!BR((?OS%7X>#KX7-GTSE,W?G6U&Y3@N2M4U! MOHRZTU;[M.T)Z/-!K%>!T^9IYV0MC"!0$'SJ&S[G@TC8X'!KX](X;AV5]*YB M\1>AL);LXX[O]3?&(,E$^%'R@8QD*H5^(1]:I^TR$M7+OQ2/]3+0/#UJ;8'( M12;NU:T@BWG#D]?@2//HL'7H*==*""_&90/G<`I9_S:X]`$>A-'IJVG+<=NS M<=6KOPB'#<*\=KO]7!2N52HT>(&/BL>O9#F.#QO'?D#\!(B78[.6*T<@(5MB M\WI&I'-RW#SV#/AZM7T]PW%Z?-CN'#\'=H]/9866%R(0?K"S:\O,L!;\_G@UA):7Y3X)\!YLG"MXN!E=#8J M9:Q8]R7`UU+=.FHT7H#`-U#LYT-;K\I@XE>H\G(2(88"J`ZI9$0I_?KRU/,R MFJ<`O`HZS\MJGH..5TU[+=8<-9HM;VN>@/!R9-8[/4#F:"MDNF$HT1#RZ(;+ ML!];,[EUY:[3@?3=X\N*]5^&QEI^.GHW&K4BYC$5XR9,8F*5+U8>A#.3V M3N&P<]CL-#S.K(?U:MBM]R&')T='QZWF2[`C<1NK*!2)QAI#.N_'092AT-U@ M@4;%W31-Y"!+,02[5VBG`=M$11$,<='KUOP%4WERZF4IKX/.GTKD^FTZ:9P< M^M6Q;T.DYV8@<%Z&\4J5DW5@7@FM9U=;GHO73UQ+@&;K%<3Z2`9S\^<](/13 M!$ML?#+U0Y2>3YE.YY%XOS?AR4C&9ZPQ3?=^&*7G/_#)]/P?S>/&.0X[F-*S M?S3;]@]_ZA#@G;$FS&3W<@)!R+68L5LUX7'-/*BQ.Y'(X3G+@9PSQ+#.(3J& MK[]G.I7#N8$+*P_[U/;SN??YR?=^__L!N/G_L]V`<49,Y``L&J7P@":T1>O\E=8I' MO>#CV>=DQ&-;#E]@JUP@M-B[^[%PI[ULQC4;JF0B0@:?;G]C=T$BIV#X:^SC MQQY3,;L0@9@,1,+:C1IK-1J'.)"S:S`Y8];C8%YDS`FQ2$Z`GI!%5J=020T4 M1!54XD$D^#Y5.%\\\)##TV2J$L)_"0'L+BEA<$0(G.PO406?/A?C")GF,0WN MU``XXZX/PM`K(\!B)@'_%%B!!^O$:(L2H!>,>3P2]#;&#AEX9"$=GIQ_$B&0 M+;"/X`-LY]0@ZMZ?GK,W.*\8;UE=#"#\5%*Y9#'JK>%:@0G/TK%*Y!^`>V`C M)D`Z+39SGP$3KM6#QZPF[)DW@DELD`A9Z[`&&17^1[B8%B1<35(=&P-*D'\T M9#)FXM$B`7("BM#X)_&*6O/91^K-MUOUIB"H]-JC"7:#@97DVM_X?=8%B2), M`(TL2AU=A%<.OU8&R@8BH+V!@3.PV=&\KF80Q#"=#;0,)0<5@74*UAHPS("H M%0"LO8?!A$(9B%F2@W+_#KQ/YPZU!T5-$X9)"V!0O[`)2O.`Y!IECAN'`6LA M%[E!!"\@"381R0CV:S8&_SR85^`P(W;%0!2,(/496(G(O1!\!'>5"%H:-[%$ M66+C.V;C@3+"C`\A-*`%1:QAK9M6#L#+NP4R`AJ1&HZ8^.NZXD]@K@1T.8A[$?L13A3Z`;EG"_[W+T;= MVWIG?X_/-8R,^8@DVEA^$<&N:=^23!,)LC^%S64CNMH8X7X%@4"GC/X`M_M+ M3)Z>7"6>U&12D'-@9SP9DN!$1^2)$98:_"Y,>`SN MYU-9MH<91*CH$8.OL9I!R#$IPY9R<#,J$K`ABV!(>LD28JA>WF)TZ`$R M$>0-[)_4N9Q-P,&BDZ7O3,]ANRA>L,^W]J"XYYH*KF\++=(-ZYFJ/[K1IMKG.@.>!HK$`BJT:!?L08HRE<*M55.)833IM(DL5G()LQBNQU7OAI&:.;-0 M];YL**"CQ7HV7AD-=,KT1T(H^K$+Q'NA,G-PQ"J/B&_;CR[NKN!AXN2 MC6_`8+7*<;@PF&/7"[P9."(]@^4 M"6*1<%&4`(*DD74I/]4*ZZ15-,'N:B2C"ORLJ"E7ZV871VHO&R>/575I5 M,MGEC$U@>2KFI-,KU@6?1_BBS\@M`,K/E_V[?7:AHH@#_ED,FZ2-:YQ)"->( M!:]J*5Y:2B19N8"H(E*F/1R@&2JVQU3';!("JCR&J>`$(@GX8T@]0$NATR2S41%Y$$P5LZ*J!^:)0=2; MCK'DP4C)3:T-PQ@C(8/>(0_#V,PFO`YKF.*J60\C%17R*6^00JOON846X;V&L?UK2Y[#I1CY@N MP[Y@0(C<_2I2#,*S'1/&*_D(%MBT1.^8_!G4N.G]1H^!O)8V[*>K63JM%!3_ M:@-F7[`;>',7DMD'"/$%AW"=5O7S8UO?@$&9%L,L@NT>BLK5OT`RBP5?F9AT MFC)*"2FNYE$M+]<1`$*1!B2FJ18]MCOX!YWQT#19U`0P#"$K59.R?Z>B3SRW MI744MQ&DPJ1$>',':+1A`3K3'`?,##3;M+I5)OV`^_A[=9&]$D"V3U_W+FZKD4M5T+O',T$ MX."T.%FF%/1Q!,J=`/DAS)@3"*/; MY&#JL-4SGH2:O='"A)G8B!9LU3FIT"0PBFJ M;Y@JGWBWTM(=^Z?OI@`/B8OMGBP8 MI$LC95ZN#=3('"S-QL`O*ON9JB)AXE7.<;P]C15$%;Q8EL0K\$\P\\+)A(9%:XF.IW`:B"&>2)6A4>AGJ#=$&R94 M+UM,(R1\&:X$N8*42"N/'E=.`SN*&D;G;S0\@'G2NC3^P&6$)W`(3@V'&"Z0 M7X5Q4SXW!(89A9Q62<@,+V!0EH`<@PU(?X*CN8.OXNJ:C2JFL&VY619L$XTE M>,I./ZR"`90Y#\8LS]Z98>W? M5NJI^+GR-.\5BIKE<]B:?XPV`;3A^]?\;!3?_YZ%H_)A'1[W3*8FD"9)X$;^ MR*?8O%'9W>O>'B%=0'SPQ3`T:N2"/>+0LJW M4;_7Z:0LUQ/E#N%XDR4ZPU05K(2M(Q(JIZU&S>L*]/;@D_%>A:I=&"W)\'`E MKP[%@5K92?JTLS]VQ7(%>WE2VF!X+##G)"2WF M=>L.K?W:1J$9/E3;-.'.T+&F5BLJ#E-SM[.&:2Y M2EG.%6Q#RVV@=XA4J%S&6,S&,GH,UK2.EI+%>9/O0N.'SXH= ML`UVM(SQ9P]A]OZ1C'>S:)\;,)?2WIHHZ-N=H_W=C16"1$@.JATPB&#.GL=I MHQOH*JFSA`>V!(1J9JN"F'AC_XR)=89":./]Z`18V@P3]24+W&AMOB(=V8G$M+(7T8UWH`[SB[*_:*KC))F(WTP%3L'P"Z[7X`6TG M%D<3#,#)[V-QA(H-:F!Z;FNVS\[#,Q21I."_9GA@@L1'DPSD55%CWJAQ/L(F M/9?5DUG'G[N#$7/;KE--UI7AOMT+Y+FU7P@*(9?]1V$8R;:#;'VQBPVEZ<:(+`HF6NZ-//>>CQ MCS:YV%Q&.H/2NEBN7";.)46+1*!#/F[@H9[SQ>W#0E$KS`IR(@^03"AN8NR% M6QBP3(V](0G%'AP8.!QZS:3LIRS"GSF*;?UL'S3[T#_[N>O^A(^\XY^W:VKD M#MER,DAY..@*A"":^G572[-XA$V`C;08\("N4M` M8"O%VAXY!$).J=7?%BSL65D(!'@3WCJ=!A%/_6<<,+0W/9+[&!:%^Z:`1262F3E*[-!"*. MQAMD"1(E%F=T4P7#NX*I[C**=U$ZS"B-HZ,QUR^G&?7GFA[S:992(B4#L@25 M]%>?Q4G(Z6`9X9.VP"ZSO"L3&*1'V:$*[?#;@-W!M?5D.G63*FKV-3\=7Y`Q3@=*J(TU&S8@`<, MILPQHZQ_(/S[-9C4UQU=.V&([HG(F2!GZ5#@9*^PTP!F2Q_X M0[FNK8P.5R$#<_54NL2KN'^Z;FH1R\XV[]$Q$0C]8`#V2NCOIW.8?A&%!2** M-)@]^I\\-O;H^Q3C9?O]V4C/9)B.S^A./&!(!W^(7<2G6IPQ]VFOP`=121P< MZI>"9,S1.E!IJB;%:+13-"-T,RRR`''_:)IN_/,6:5BU)J`'S(C?[[5SRBT) M!A%;XF--X`/=13AG%GX]5=,"2)[N2J: MDAS5R:3.4G9O[QM$CB1<0(`+@)*UO_ZZ9P`2A$`*`PQ(0IHD%=-\03\SW4]W MSUM/]J,2:#3?*)U+Q- M9OEQ8X5]%-2"U/IH`PYC>GW-[&FVVGY[JK.TFM9%^`-I7ZW;EZ&:/5W=;E^E MKNR0CNJ2Q/%O2JYNGI*_J*"J7DHBS2LZ$A&!!%OA+Y:N]1S+$&N,6QI:&=6O M8J-'2WE%![6M.6K/Z-O;^[?K:8=R`@.`I$UKUC_I`%F9A4L8I;SY`"*X"^JW MUM%[NF;O3;$=3&6DM1Z/M6J:T1L8VZ-JB9O]3*<]RB98>>=6=\^2EM6Y7^]/ M?*>3J0;AQS59+AO\VMSJ)\U7?U90#U6>E0YG"_"@*3U(K:L2M#U M3CS,S98TB\1YL3=MZUSF!H\J3VS*>40YC]@\WS_BCJH]CR@R7>>#3T^:IG?] M@,_]J+'"MCU%TW]FU6&P"'NZD,+J._C/N-#BLENV>G1O]CA\5$SF(UH8K1\P M25+2_A"2+.T[AZUBO25+T94SPTZH4(P"`?<.[1T[IYTZG)Y,$T5WWB"I]<&@ MIUG=I+3@F;$#*L$\$"WW.W?6C+BZ58.WW]QH^J!H+&4WWQ9SK<[&XK=#7!$Z MZ'0X+64E2&.[PW'GD?(OG>$Z%47*XB#P_O0'DK053<935KQEW2')_1;5\O[(;9>-@G>2^YS<1I3=;W%NRQ8W ML27)?61J>7_D-KG)S9)R??`&J2UD;D52^RC5\@ZI+8?;:Q.2Q'ZC6GE_O#:X M0S8N,UMOD-6&C-?'J!9):5Y*<\^,M\OHX]WX+W+6O,H9C\ZR_WA5N`?O<-QK MV[SG0JZ7MTF8N/Z;"MU]U9";20ZM!$O?RR:]UH-OG7.3N:HCN=+:Z2:1=Q53 M?[%LNK%+U&%%&5/>]E874*9Q>1CZOL,KM>H,L:-ZRUR@LEZ!-.#<"M%[B MNS1JTZO*:$T&5/FJ.'RD/*6@"H7B*9)B-[=2IK9B..0J&+%1!B*':02JNHV\ MGO('\1\)#AX`CQO$)RFHQA4C5H>9=N?0VL\O1BF@EUGXA/94-O66>A/KD_ER M($K?W#H.JZ(-^N.T./U-R#D*R_JZ+[Q-/,/-RLW\24DI6:^9NMIR,[&X/8F: MM_,4:R?65*73D3:>X=WFE1\7[.]);7D=G$TY='M:5F%ERMA_4H@Q*TSYK@\\0S[N*V^H6;LC,=2MWS<\; MX_#?\8*Z%9$[16!=$E@2^-T3F-X_R&8^.\5>3;=[5M>XJP(!*`>TCN+N=PLW M<%=3)7>/C;M6!\.N:GZ&_UZ4/.T.;MZ+!`Y/75U2]^BH.^@DC,-S5R;,Q\==O8L35:KU6>MDW,UPR[@KN?M.![O6 M9UWO)G49;DE=25T!@]V.4E?K*'4U25U)74$9F@/U9ZV34S7!+ZDKJ MOE_JJAVEKBJI*ZG[CL>Z@\]J)Z>8,]R2NI*Z`I:'NKD;$EA@='*XF^'NX(XJ M7;+WV-C;T;W,:K8GN&,Q;(5[T"W<#=A;K(U1OR1#Y5H+Q2(->**5!+&+!_B& MP>QLOO##9T*^D(#<>[974&26!) MX`X3N*OK$=T\;":K,\C#9I*[G=S$(ZLSR$T\DKJR.L/^<4OF2N:^UX195F>0 M";/DKJS.(*LSR+C;3>YVEH:^D2"V5 M0;L8CR;?SI2;X?^<75/H[55G:-2<8^O?;V0V`EJ0*%:^PE<6/=:;P?23\N#& MBA=,E[0X@A_&,6"(X0V"[Q)ZIK3T^#DMKW`71J2GY)Z.3PM"Y8[9L)*X/Q3? M2Q\S!`>!,ES?9Z?RDU79!M^;>XG+3G1[\T48`\#;9W`94>+B`?H( M6.1.V>?0U.D#_=6,D#E\,0F56Z*$3P&@>O`6RO3!#>Y)O*TI2D`2^&E:(P)@ MLZ(0T!N)<@^LC?#8*4K'`^?82\K4C:)G:/^3&\UHLV\)"6@!@F>L!D"B1S+; M*FVZG"]]%\L%4,'A`@6`HRQYM,<*!+BWX3)1/IH]V[)Z?5U37A:LT+%>`NN( MCT9OH*D]9V#3.@R/KN?3<^;PT,VGXQN9LCSJ<:C.%LL(^YN=[W_R?)\5*:#G M4K%XP9T70Y;#ZA>`:+V/_0U_#LK++;PLJ4%++6QTN,(Z&_Q;[,78V="8C=/] MK9S2;X7<7&?ZJX/.G?[_L!'!MN>?[`1PE10T.RNL?;**,7JC`,1FXRNE!"(? M#=J`/@U^_Z"O.I`CG3B)O7\3UMD?-J+-*E%;QY,*J4\0/D7NXO.H:/T=CN*UT"XQF.O\V%7Y9/7>NGTA3O[C3.+;I,;W,_;HC41KN'MM;.& M&9:%F9]&H[.S\_-=%IJ&`0NK632QUM*:0JM7.+:`4%3,33CM.0M9NZ!RF$U6 MXZ)ARS_N;GK--EH_\TR`[-!&YFL'AMTS#7'NMAUE"'Z$BHO#`C?843RFE;PJ?4JAPLZM#QW( M'L7*ZPA_8"/?DGF47T2[E#:,(`/[*S_*/:`JZ+0.O`/;3MW4_\T9S_Y2MF)+ MC78]Y;@PE\7&(@U)M!MS4VO5/^EHKK-P>>N3_68`;>-Y)=GC4<7DSS`0"KRPF6L^%[BW:P$,RJ-)=76Z_/83Y:%DE]Z?UKZ7N M^<5X"+P=7BI7D^N+FXO)6!*XSMI\X1**.R]PP4R!=4"-A%`+IDO`&BZ1SN(O+@D0L?EW87"Q]&.+A4 M"5["5>Y#_`*8])1$`5M'IC"HD<\7/GTZNH*(0//^S7P&L)P.+MA*L4_)LOHD M6_D'IM5S(SG?1J%L[%7(K:&GVQ:2!^CB^X>2,OIW&ROG`5NP=Y6G,/J+-MI= M>`G`@D&3-_62DK5U?`:%\-&VX4E:7^2=$&_*G/_PXB2,<.CL/^.]"(\D6)(X M51_N=P@3ME4B7MYA;V.59+"_:0@C[MQBPS2,DS0./85+?X9[N\"-4R/*PAW] M&=KUDBA4GQLFO,VB*)0%)'+P2]#Y(@JGA,QB&CCIXV/7IZ:974V!%VU0HPEQ M;XJ2X\,,+.:6%7DF]#8>)>4L7@F![X*Q`EMB9O_KQFWT"I4;@"IF\*X?+N99 MW>B,&L!?>'CLL9TN5.O,\";3-T`%$*A0&@&-B\CG%9E?9_O M;OPBWJS@^3[F$YGG@&X"?Y+`&_`=VA_PI9?=`6^F#<27M$D8]P."?YV'\#IK M+X7BX20501L`%TS(CCCZS^SRW<*V4#>0I!6 MU$6[2@RP//#.+K@B#T3!8\,@[PS6[(H5QHTXBY"IFP-?U]P+(,@]:]!W\$?1M1#1=U%$4W,<42XGU]?*9*P`3X97%S?#RXO_'6)NK^PKN3]4?D/E M3@)E#"G)_!8BOD530+6W$0W)W1VP#?F4!H@TB6&&0'ZP;:IT6R;N\\,OCC%5CI5+,.5[TE/HIMU?,O[9?]OX.'M[\+=?V19? M5P&;A'1@&D:+D%GQ)V6(Z4$:T=)=EA372GYO4RA$^ZF+DPGPQ:>'$!*[$]Q8 M.X,4[C:&T(1Y,CQG'7M!1&Y;;R_;U\NDI-<7OFB:PI[I@G;^#Q+(Y#G#EM[G MQ?*P33F;EX'EMP0K3RYZIGLWPHNU7-9B2#%CENG,270/FGW"#`@TM0GDB798 M@)7_H]568NI6UZXS36`B?#2JC87(X9298;/VF#FDK$L@^DW7["R:ZK2\I-#`2G*8I MFL(O-*V%!C^L\OS2_.K7#'F:E&*?8<:-22'N.5[]!,:R8<2B4;KI^).29>FE MB1L-470$L1H'HP[N-K>APYO^D_N<;LMFP]9,4-I_F&3WLKA6Z#P8Q!)FM^P- MUN8`68`=$)$PNG<#O-J.?I!V[+8Q+-W5#8+*-/!1UXV>:9F(#_>-L^23Y))1 M^,2GXP9F,B$C!;T@#QX84@-/A]=IVAV3Z4L%8W>=O$"`K5D_#[)_\(3,YF&P MM5R4@&X4LW>>FA$5?8M1?769)'6T5VXTB>ADR>SOV.@K$M'#<1LQ>QA/[G)Q M&O)[CWWPY_7I%?UZ_`'&,U-O[OKQ[Q\NQN5+AN336I0K%J)X9V,*Q, MTG!UYV.U_MR"#X(?_6<;Q*(P(=`*W;=':)/<)85-NNT54#DQ8E!5Z['ZJ%B" MM%?:5A`I#F5MPC9#*92JAO6"$#M$-4=5S>8$HQ)%4$O5]/YN5-7H():A",NJ M#8M&XB%=!ACAW#Q-4:N1,H\$AL.:,;#6&%X^M[;DET0K2%9YQ'Y/YV^K#O-W M";9L(]?D[,D\$O6<1+V"1%TUFTE4'93"T4:S/W"Y^QJ&L_@:1E(B M>E?K:X:1M^H-"34`\':VZ?1-@?*YNQ[?:*KA M#-;2ZHSD"!'-W^(GM.&:U)I_BB`^&MVF5@.$0TOT-:0V"\NC&,C5#3&C!NW5D#Q];J==DU\7TV+OWF1G\1'*Z?_<`:$$2( M&X.D(6=3VX4U@\6K2,VVS=91<6O1L57=J0/K*]LZ@9J>S;W`BY.([B\0J4A5 MM_+1]Q61`A#RZK1OJP-]CP"YU0N.W39MM3;$2;8,GWXN)(O3+%MU\CED44@M M%-Q\5+6!U1>,@EM!1E\U=:T6#+;1]I(6P1"1??1M.K7!$:? M8MLW)=0$T50!(D#P!Q'=,"V3"\E%NB-)9#8PL/,9>D%"#0#<`:.OF8Y``/RQ MPK)UISH"JB;FI<0$B$T%Y![/*9D_'FSV?&W)_&[(&I@#LTC"S)>XG:(R1V;$+R@VXF^N+$WY=?%CEGN-;*JXD7"WJW(5F&?N5$`03C. M)O#IER"K/?7\94+J38=M6TZ@$[Z6GLN-7I$N`.RK'-D&UC0,P*OIM<&.22(Z MLQST]?Q4]88$;O'\WD-7'=T4)+Y&)J/W'56M*C\_BR(XB\D_FE=L@[RE@5C^ M3,4:Z/UJHO/S4Y.[K!K59>@&D\B[]P+ZP3DA\9@(F=TU-\:*A-YR" M/"!T_DG*OC%P!&'/G">9T14!\*#C,"!IM=IK$CUZ4Q+?K'?5M3,6J8FBQ<8T M\`U'UQC^):/^YE)PPQ9]&WV]^`W3'CQ5,KG++2Q/%NQ(BQAK>E5.(T#\4W$& M+KNU"HI?L\Z@KVH\L-;C,G:0Z92P/R\".FQ(U\?98KF8Q&IC!T`5L:*@T3*GZ]I1E]XIZ;G+.(K]YF5NVVN?,-6[5TP"R*%8.36NM6W]#V#Y.?Y M8&#N5'@=D!&,6R]S)WH%*%RW^IKY"LZ"6%%0N3?-&';_->-L!RJ_]C7;Z>]T M376PGB[)39ANM[YR(U$FH#F.M1-KB5QA8+DW\VCF;I_?(M@ZP5YUC(9H8A?F#$Z=O]O6-:86*TL7BYI^/&1A' M@+M&8J`9IM4W12"'4$+/Y]R$0W8T"IX!OTJ>\;:3!"]!@7?9X7:QH\?J@L5" M;C!&/!!D?OO0-)^+X)'$XJ.-^JK;*Q$L%G(#"SD0Y!H^Q#1U6P3NO&%A(3ZQ0T]+W4*_ MO*@FD'AU;:DM(^)695^#P6]#3-_)(HTADSO12MP";9M(43"YIP;UK;;6,E3^ M[1FZOM4*ZV`MG7)L4?6E\H0`%!3;6P/(O\YH]OMV$Y3C,,#"+I,(AY+I7W(G MN4_)+::3?P:\+-H@M4AJ` M::!HX6#XJ:TZINYP(WHY893MSDL]O:!M!#MGU%Z*%`6S@4KW"+/&]F[+-K1F M6*E_9SO53FFYC2L2>2$[7C[,%R,4O`^@HEB1<)NL].\?;HVU_,VE_)J0MPS: MSK/RCF('YH7!6'7A8F'SGX8[!M@UEHL&`]5V1`#'GV&-;?@#YW@>79]6WJ,V M5O1#0M8+K(&3GW?GD2\:._>:P>!(D-^?7_5>1AE6^9: MW_>6D]486`T%[058[=V-7.BJY$^C,,#ZDG07+GN=>)!>7Y,I?!.C)<15&&_E M:DSO+WOFQK;WAK>4AQ]]P[GM=S`P;5/;5^LYM_Z"(_Q"`B*H>DR#/B3GZN)QQ M=$^59E(<.W[+"!B.0'=$EFM(K+V9Q30^'% M2G$/=5H'!&%<`?8K%:%47VX&.>S4F'G/=1>+14O(>[*0ZDZW`ED-;B1C%=`< MZW/_8H"^?;H9(M_[!YW,%>.H[?F=UC(".TZ)@3GV^??VJ=>%2WOOMNWW_&YO MWZ^HSQ`3ZUR?M_32GY7X$6?BKFC8$IG!#-AG110)Y.R*&5R?K?;=9.WV=0G,Y=CQ3,='3>CDR/#6[9E_@83 MS7HZH3>4`3%)C.U4@YZ=89]P-@W;(>RW<<=O+77H9(N?K*"2G-[0"-F_$"NY M5A$K3367L9A0B)&9:R>XX*1X1H4Y$>&9,,P\6(^I64(8C$@0IXI&Q\XLF#!L M`P!^$[7OJLB:ASGDC68V[!WDOH+I)\+MRHZFE!J]BUKIY(:X7!,%BS"EA@6$ MOXA8J61]+&W"4>L@?15=S>V.!([9N73;I1I@=Q7UB9Z><[FHSJU$ICYFE])0 M'U_";J7H5702&';/#*,:XGS$)H)%X"Z(^B``.0/5XEIR%L#[7>Q?BUNOA6U\ M2B.J%`W/:37NY1+ULNI@>X7,>"!CB[>;5;E$O:SV\,C(X&XJ>0AE^^Q'#)M= M%6[;Y.IEN(_/`$@^4/H)FH^(F6O89RIY=;MDO2P/H"&``7I+EM5"KE2@7DZ' M&)JR&3/)E@>IV)=)\D$K6#&E*P'4R_D]OI"@`C0%5`G0>R[^(8&M+#3*2G@-EC5G2K MQA4:A"#FR?0A/!U?@VP:2>;L`]Q#E&NII"",A2N51"I!2S,C!G/NX!GBP4G8\H3)M]3 MT=V2[ILPJQ\KV^16,B2?^YCZ1OB?H!E0IF`R@:+"%0F`V&HHGJ+7^O"KQ8+[;<7"_4N\)N+GXU5L;/9;&"0%>@IDC4C;0WNQ_^R#D?\`4$L#!!0````(`#2+.$-6<=O' MK`0``$0<```5`!P`;6-G:2TR,#$S,#$S,5]D968N>&UL550)``-3`T)24P-" M4G5X"P`!!"4.```$.0$``+V9;5/C-A#'WW>FWT%UI]/VA>(X(7#)06\@/`PS M'%!R=W-OA;TF&F0IE102^NF[0)M MN))'7M!J>P1DJ"(N'XZ\KR-Z/!I>7GK$6"8C)I2$(T\J[]-?/_]$\'/X"Z7D MG(.(!N14A?12QNHCN68)#,@%2-#,*OV1?&-BZEK4.1>@R5`E$P$6\,'"\8!T M6_N,4%I!]AO(2.FO=Y>Y[-C:R<#W9[-92ZHG-E/ZT;1"54UNI*8ZA%SK\_#B MDGP_N;LB0?MO7GX7YH>#R<>"^[ID!@H,CS6!N^)&W%N6LVU+ZP>^TVX'__?/5 M*!Q#PBB7;I!"\#(KIU)F%_3[?3]]FG5]T7-^KT7FH^MG.+DR/HUL;K#>N>[HYFW:AKHD&'=H/6W$1>-D[IR]9* MP!W$Q/W':95[E5-MP`@UE0^`TRGQ70,.'>[&@,8,TVM-+.#;'< M,HTO80R6ATSL!%9J61^ERTUP`V1NXIN)6[QP8+:^NLU6#=#=Q$-FQN="S:JS ME=C41W:M+`3T&AW1D5?@X5B+" M'?[LGRDN=E78-MG52]BC9RBDG@%.\)P2W_E#)D=9=WAL9="C5%"A]-[H!''EV92E*6C]?>1 MJW!I?>SJ+_OXI0+-<^?.:*02QG>$?FG]#L2I)YI`<@]Z1]RB:?.L3(C="%.# MYKFDLL>[HF4V[SHG(6938?_WI,S,B\S8S&6Z)E_A;8$;YA9D!%%&[@1KJ/JP MV>DLR_F`4))9K5\R&9&%!"EH-$E?7MP5<#O(F!<+>(U[G,'3=(0M$5G:DTS@ MW5C+Z[T">+QM"F(E1%1,UJ7>!;^L;4"B#>GCCY(G+[X4'%]G*1YK@:U[(R@U9^6DZ^E:9"E"%FJ-$U?7M@6H(-2:)>^"U.RM&T:M5I]6T#O ME*(?I*MI+I4N+3^(-1W+#B5O(:!N:4`NBU,]LA1,0\HER4JSZ;@JE\.%J/9* MHW*)OE`K+/8_Z#6^X6VME@NA],IW-9?X3H8H25X*N1@.TQ]?\I^HL.4_4$L# M!!0````(`#2+.$.26QX@TAD``"%7`0`5`!P`;6-G:2TR,#$S,#$S,5]L86(N M>&UL550)``-3`T)24P-"4G5X"P`!!"4.```$.0$``-U=;9/;-I+^?E7W'W"S M=Q6G:E[M.'>>338E2QJO*O)(&`I$02K]3( M8.=2CCTC=8-/`P^!!M!H_/#3XSI"#Y@F(8E_/+DZOSQ!.)Z311BO?CSY,#GK M3+J#P0E*TB!>!!&)\8\G,3GYZ6___F^(_??#?YR=H9L01XMKU"/SLT&\)']% MM\$:7Z-W.,8T2`G]*_H81%O^";D)(TQ1EZPW$4XQ^R)[\#5Z=?Y]@,[.'(K] MB.,%H1_N!KMB[]-T7+E_.8/`1?"/V75J_/');.C%Z1,AO_^7R][EV_87R^_F[Z\NKYZ<_WZ MRO%Y:9!ND]WS+A\O\_\R]1^B,/Y\S?^:!0E&K''BY/HQ"7\\*5GYY=4YH:N+ MEY>75Q?_>#^)P+>D,R#5'#,^ABDE>"_G15B9_RCLZN79Z^NSA^3Q4E1 M^:(&*8GP'5XB8>9U^K1AO$U"3KN3_+-[BI=J,!&E%US_(L8KUN`+_J`W_$%7 MW_,'_27_>!C,<'2"N"1CH]:N-Y6RW=H^@P# MROK>39B2-(@.`E_6]`[[%A]6XWL]_S7-!A5\6$V7-*NP(_[AD/U4`8X?4S8: MX44!G9=EZ.#$HT2_FY>]*YW,*^5&O+,D5%DCHLAED,Q$N=OD;!4$FPL^)EW@ M*$V*3\[X)V>75WGO^)?\XT]L[%V3>)*2^>?W>#W#NX<("W\\,WO"/MQ&P^D[(.DD_.Z5K,33NS)*7!/*U9UD#/ M!V,:F\')XZS4.H^:(JU3JE!%3!=ERJBD?IWPEJ&:U7LP'I6P@.8-T,JT3Q@),[3H,J[2 M(!JP>>3CS_A):YPDYY<8&IA59M2$`%%#C4S#C5P8"6G$Q-M@1]&/35FQ"K.J M7_OB@@I408'R=R!:7@%(.UAPF39;>;?"RK<8#+;4Y'RWNQ)FG0`5(5!,4"'3 M4B(39B[$0NS[M,&.#@.RX&!NHF"EL*OVO2\V*&$5+*A\":+U58CJK;Z305RH MC;;N;BGE&,-D'D2_X8#J.P.]J"\&V,`69-#)@>"%!9RT5IN)HTP><856.X?, M6?D51]'/,?D23W"0$#:5'B3)5EKI<)#WZTY:8%?=2HTP"!*Y(*PS:9`4$],` M<6=XAS>$IF&\RL):]-,OC;CG.:P1=&TJJY0%Q!XC0"V)ODG03B./ M14)Y22VR2;"YR\;1%:'Z%9":E%_N*"%6*5,1`<04%2[-RD<>GY?+MD>(\786 MA?.;B`3UQ7B-C%\R*.!5J5`2`$0$&96&!ID@$I(MCC'[((K)?<"J8[1-11PJ MZ[OTW:)1R?-XXV!`;=0Q:``BD@-,W=)J*>#E%&7*J*3=YAI<-K'+EGUNV&= M&$"VU+'9N"+6:H[.E",$V8V6-V$P>`K9-QIXK($NV44:&-_EGH0XG,2Q*<)A8:UH6\QMXI`5:"[2H28$BDA"7M M1$PF_>D$$A7R]0$G1DBR_HFA@2OSHR8(C"9J=+I-B4#H7,.@33=([COQ@O_# M@Y`?@DB$*J?=@-(GYN2+LV\:XQUUO9Y%:&).Y7R"BR(8VC5!*]&0*2$V@T-S M_@/>J\,@Y"B]Q[3R6FGJ0"7HDVIZH&5>R5)@2*2%5F>,$"R6GE&F`8,L&99; MUE@-QCV5N/^A3P]:'OUD63`DL@"4#B!0LL$T?3I%XXC'<_)^B/=@&^YT`QD2 MWP?S^S#&](E'-!?8WE&2Z,Y4F11\$LL.O$PMO308*_=WY$K MI=)='JEL/V^`,MW`5VUIS6LSQ$ERC4H/08O24V"\2UJ;;K'N_3"K^.2\"_@R MCTWR8'IG!Y!UHHGT".@F?&04@^1'EEQABPNIE&QIVF%R'!5B8(BCQZ:>>70@ M+9BP/I>O!B<9*(V%=2&?!%$#+'.C*@&&%DI8TG817F(VT5B@&XP3]"+&SS]] M>LRIJ'&6U,8T4S^I!-/NQO:>CJ:=(8*TT#X,@UD8A6F($S;HB>B(>Q(M,$VR M+`Z6`<1=W2=9FAI5II.K+AC"-00L>H<]M#_5\^#*:_@2.G MVU:02:$E`CIL"NFE(9*LV?9021&(R\,FAF0;I\DX>`IF$38OR^N$/2\Q&`#7 M%@P4DF!(9(0G[4;GPBB7!D,>NL4+^770FZR3]TPA,^P:B]3"D(AD1*C@$I=' M_<<-CA,,9)K>V^(IN<-BB6H<4#N93`I>YV16X)7YF58:#)^L$&V=$SI#N3K* M]6%0;!"GF%56ZC36Z81]4LL,N$PKM2082AGAZ?JG0@G6F'=+4C&U&)(@=O.: MC!H^Z>0`O#2+ MPI781=8MC6NE_8:-&B%7`T65HE[9M*GE^&]2L1I"B4$2EA?5P[/4,KTK2_C= M8Y.@53?8=E_#XX4,3AT.4HQB8P(G"$3953;I5@$,6,X#%>P!RN@!*8KR.`TS(#&A\8;N%"V;)MMTOX)MF4;;\1F0D"\WC'-(U.$&>(` MCCX'AJN2WQA%%P.J48HF#3"\7E^>7F%-@%%#[R(4W1U M>7IY*?Y'298<(]BF]X2&?^`%^U9\P<\W7)5%0IXO;B$^)U\GE<91[AMRY*]1 MHZ4[B%R8:Q`'0UL[1M,-12K"OGIM8.PY>GUY]?)U0=KO7IV^NGK]9V&NYBX4 MW6:H3AK`K33*[66U*!BFFO%)6S<[:<3%$?3K:"IG+\1])YIJ<%%L\YH:O2&F M*VMD+3"\4R'F"=$A)8-Y%XYJCCH(>S(==7_^^VC8Z]]- MOLFC7M&+7O]FT!U,@43AVT)[[:L7&C5(P=B6Q2&ECE>BIJ5;<`^J;R,/Z_'7 M*E["8&-UYCD.Z(B*#%,+X="/,15)%9VFK7KE]M8(;`;IUPITFO#6-1OAUB\B M)-FB!J^5@=*\ M'R[_FBZ?MI1#N*$)-@JVM11U,`>;K*5620AN&:FTY-9PL';2;&E!M,DP[:`& M9LKCCE6S4%H:E`$-Q5+";NLX;-1HB70N([!!'%[79P=K9AG0@;=!XGXWE5;Y MYK[M`R]E?P.03DP#-[H.XCE9XUV*94N8A5;:[^$:(^3JZ1JE*!A:F?%)EQ`) M:;3/APTM\_4=?L#Q5AO#M?_:[XY+%51U7R7[#@PA:H#J#,B_AM':79*DH^4[ M0A;)A$1Z/Z@FY79R ML\&N9'33"8,AD`VAE-VMD-^E&0`2RUG.L5E+K:DQW:CA.?N;#7HM%9Q.'`RM M[!CE)'%[#1&P5M:!0;$)%AOOS)[W`?V,2V^-;H/?H.`U(L,*O!)EH94&0R\K M1.F2H$Q!$&NG`H-5[W#,NM2(OR6+=1B'O/M-PP=LII95RZOCY&9"Q9DRJX!A MFAM.R>G*M+)^K*('@W/2J._J';3L:SGY6&"XHT.F/F4E>U;`N)*M+PWU=RHH M)5OABPQ5R9B]&#S.2-BDT]\X+7&&"P+A"\__G*'G"<8=)W<6)>_9NJT&2(F[ MM1IPN.4"4YW..U];?I$K?0MDTB?`V<:PJHQW)AG'KK(`+)Y8QBS>WR`V4^N% MR88D;/@B2WBW`^1NF-F35DIZ9XD:JL25JABT*T_T$'7TN*JP!IO*I@T,R2E M*P*#$4T2JX%620I8%P#!#A4HU#X(S^_D5AZM[UO-U'M@@N,*W MV_4,T]$RBPH:B./8;X,DG&L,=E?WR9ZF1I6)Y:H+AG,-`=?I6*BC7!]EBJ@4 M$7:*1`%B=;`71ML42F!A<2BW",45,-E4,0>IJ3"KED^J.II09JA%!0PQW7#6 M^2A1#17EY-$`:,,&55$@#!+NXM=&2W[M]4U$OMA6C\PJ?L\^V\%73S3KY<$0 MSP&DM-^V"T(D2R1N+Q=:X$(2F?/`T8TI>0@7K&-_^I#@Q2#>K:MVYFGXD)UY M-5/PD((\.X`'&EKS$AN6`H;$!T.78NHZD[^CF^'HUPFZN1N]1Z-Q_ZXS'=R^ M0YWN=/!1G'$&LCS:6?QKFZ3\-11)()GY`_96)OP6"$Z9,,(5!WM*CO,N?/W' M^DWZXZ<2J]F#ONXSP;R5G@R5\QGM'HM2@FCQ,!2SR63$UR;9I_QGC@AMV5/0 MBTW^U&_1[`F1W<9;()X9IE"V:\MQ5`[!6>U%NME"V\!P5`'*&+S&/)[BFF7A M=T.[X+X45S=:%G>S\HLV1C1%G->O!"G'MC$EXT8>+V)R!/&$TP?PCE.IC2($]XED]@2 MFGEH:5YGD\\SN3+1/*PH,!Q_'GYI>IJMR66K>6A)*"J*>"[7U_-5*!C,_F3\ M?=]]-_C$GQ2P]F8SZ/U1T=%&=$\D(&$T&9#*P] M2.854WY/2`]G_S(_F.^/[9UA$8W![]`J706`'8[P/J]4ST=]CU$%M2/!SRFR M=9X?UPYI[>.>_<;S"L?O$ M8"C<&+(J#E%$.A1%H!>\"+%=M#^GM2\&-($'\0-.CA$`82P(`*$=#'4@MJ$4 MZ`2W0[<%0`QN/_8GM0`(&.1F/K?8XYV2SOSW;4AQL2\W9@:E_`Q>6I-BRP:`7;\M14('6>05E63"DLP"4;]O(Q!&O$B048&T8E.VYPYO< M&Q\M&[)+K]H6TVS&Z%BGTP/)0`M8B8VY,$_0`)R+RH@>AQK1Z+7%0J,9.@HJ ME4#RSX34W!46,Z#R-=DP6)@?5QA1OAN1_R+6)A)Q4W(/SWC4PG:-%US M7F^,>:]>U@-#Q`9@M;F8.@N^S),2B-ZAEO*KM,5-8>**N5*?K%N7 M=%?W?J5Z`Z.D2],==,$PM"%@S<5:6>!^?L(#;*8Y]\6I9Z]N05UV?-YR(QC6 M-H9L7T=G`_].'=P".H?:B1?\'[Z-]"V>]?O3/KH1:^?_?0M^PR)U?/.;2_[H?_+A\['P;!_ M.S4NF7MOX@Y[B2E]8B^<&&[A3E(V>37M2#>#KMS_*+?@X&-' MM"#J3-';_KO![2W?#!G=H''_;C#J_?]LV%<`K[EM!+Q1L_;9YTX-ZM'!WVXV MD<@M%41%.JI!O"1TG=TV9$D5YJKMU;UO9E+%NW=3!3/(-,,K!<1\&(^'_?>, MG9TAZ@TFW>%H\N$.RK;K?B(=ZG(E5D7:2!A=!J?*%LV_!\,6!2BI^Q(N,_L> M99-%E-YC]!L.J#C6#S-]=);0:!H\\ITX`U=J4OYO498@RKJTFQ-"`=^<%Z*DT#IQFJ"4UD1SM?(F999UY78Q@]H M_:WYFE:YO&5B?9>_9'RS#,@+UC!)$1MEWN(8ZZ_"?DZ!D!-5R88_)U?5OC0X M+\5S36CT!L!)TI:G.^"]`(G"N4.N6(."U\2!5N"5-(%::3`,M$*44@#N%%"A M`2Y=-T]FSP,HJK8]97]/\6/Z-M+'_[DJ^Z1=,X/*%'33!$/'1G"E;0628G2% MSM!MD&ZIZ`/WVV$B!=4D7,7A,IP'/.>/3&08["V2:G;9X+!BDU,GUMJ4_*;O M=3&@FM#7I`&&G4XPE:Q\R5@),%DJ]XE[83*/2,)>&,L8K!/V2RT3X"JE5)*` MJ&2`IXSSVTN#&V^KQMB[*HUT>T2R=$Y*4:!4NWR@5]@[*B8!"U2]9\]S#;H8X7=S@-J=C#=G:Q&I7@ M-=*MN6F5F!EW=3"$;8Y9$6*\*T%,/_=E0/;F:H;W\^7(?.&1)R5);%UNLR): M)+*3<08F&_6A4MD%M++[?@0O\BA=@4@##/A>44@17KL/7\$I:X/K*&\SO-B:[%P"&I(>@5AUBR\L0#F:E%.`^IMUX!R^S42'@2&WS-!N4\.>B MM5-G_-^L,S82'`:51W05Q/EI408O(5&X*#SM,:M='L.>7;F7G](+HMVUUS;G M]$AE^R3^4:NC_#X6R3U&E=/$2E$QUUT>D2911\6U0^%B5 MHJ+[<\L&]VHX3?>#+:1L=2"ETTQI2?\,>+EE*" M,(]MN]Z*;J.'-Q2SV4B6U7,3X7QJWED3FN9]0J,+2HY5MN>,,:9.^>@F*8Z: M%`]`Y2>PUK+-B-%DR),BC691N`JTB?@T MHH`:WH90/D,OY)%00"6-EAJ#!\SF-S^K&J#T-:!*5Z%2Q8F?%I=:MU2YEMMT MR_?0PJE<%:IZY99DVJ]:UG_*`966^E;JP&P$,U1#R^PZ>W-,Z%=LI#'-C_D( M`\8!'5&QJIZ==&N M;552`=Y8*J2NK572;=M$HMH[W#,`^GRK&C* M77E9#%!SF-!)N^9<%N7"+HG@OF+E%_GH#!5?$P%4Z3IDVGL"VJUKCS?/PFFC M0U"[7<'4>/FE_-&0_<0^+CYB?\V"!+-/_@]02P,$%`````@`-(LX0]UC0,:: M$0``Z>X``!4`'`!M8V=I+3(P,3,P,3,Q7W!R92YX;6Q55`D``U,#0E)3`T)2 M=7@+``$$)0X```0Y`0``[5WK4^,X$O]^5?<_^-BZNKL/!@+S@MVYK0P,4]0R MA"/LXSY-.;82=.-(6=GAL7_]M60GV(DMMQP'B:F=FH+@J-O=_5/KT9):/_SX M,(V].R(2RMG[G=[N_HY'6,@CRB;O=WX>^OWAR?GYCI>D`8N"F#/R?H?QG1__ M_=>_>/#OA[_YOG=&21P=>Z<\],_9F'_O7093^^7()[+)_R, MQD1X)WPZBTE*X(OLQX>Z;P/-]!-M?"(NX^/GZ?,GV-DUGQWM[]_?WNXS? M!?=PWSOL>]H^/7/>3[TB"=)\OW[3_LY_\R\A]BRKX>RQ^C M("$>@,.2XX>$OM\I:'E_N,O%9.]@?[^W]]OGBV%X2Z:!3YD$*20["RK)I8JN M=W1TM*>^711=*_DP$O'B'8=["W&6G.%;JBE?D"2AQXD2[X*'0:KJ6.-KO-H2 M\B]_4@7_8VWU(HIV%\94%!8_)-1E[\C?4E>5;V5PD)(GYG$T(U)'I MGBRP!R#-IX2E?19]9"E-'R5B8JH$!B44QUM!QN]WIN&$^K("P'_UVN\PM.GC M#/PFH;+:[WA[&TCZ(8BE98>WA*1)DVB5A;M@J8[R2YY2GK^);16@@S& M_3"E=S2E)(%Z/J031L<`%]3Z,`2Z%'J+*Q[3$+YODGY3OMUJ>."?DC$1@D1G M!"=[-46W4AWZ\B=XQF,PDOR:I:JFZ%:J5_XPY>'76QY'T&U__'T.C1U&-AU= MMQ*^]C\"(_Y(R`<8?(QI>@7M#`I5/66W4KZ!`0$\(#?!`Z[*51)T*]-;'P9E M4YJJ)@]<\80KYX.A(-*E40RZE?F=_XG#*^!-(1$,WGE&&70K-(BO>$(Q?;<9 MEVZE/_*O24A*+9W@##Z&6;^#D1W+H^->8=^_X$DR8/#R8$;3(*9_H(9**&*= MK#-!$M!+E;^`!R42\I#"U(!$"T92W@[&??!8\LE'Z3#*]Q94Q8\P._(R%EZ1 M1R[]0OZ8AR618SDHYJ+);G)2\D4G:W^4I"((TP6C.!B16+'_(FEQI'MMA,W- MJX;I"0EW)_QN+R)T3\HO/RA%_/U>/DC_#AY]R62X)A,J7\U2.3&JD!R*5I=< M%;18*_HB]+B`?@806_`,1%BJ"^OSBKS$WDP-1?WPEL;+:C06?&IJRMQLO$&1 MHG5!A&>'X`04$4%\#E[S\!-YU&&P5A0)0L\]%&JTM@'#0H\;8%MM_7()I-$/ M7#)ZE8XV;7U%!.6@022#.7JCKQ1%6O_01>M7:FT#ACY($TF)SN)@4FW^E2)( ML[]RR>R56MHP]\E<2!7/:!(&\7])(+05O[XT$H37+H'0I+N]CO=7$L<_,7[/ MAB1(."/1>9+,B=!UP+4D2&3>N(0,R@KVX/F%QS";"L2C6JY(=+"L%47"\=8] M.&JTMC@\S?SWFLRXD'/;;.E$.TJMH4""\LX]4/0VL(>-JB,GT)A.N-!.'%8* M(I$X<@^)2HWM`7`U'\4T/(MY4#7K7TI=*H:>L[EG_0IU+39,?#KE3`6UA[>@ M=S*8IVJ!'!Q4VSQIZ;#HN#BE1AC$YIPO&P)F%;3B6B*8\%QI=`Z4H^('G>\M5:/A\PEG" M8QK!D\C+Z;V)TV3Q9+66Y8^_%-;)U]9T-!'S MG!Q'O;';M%>OGR1@WV9%5LO9"I\;V;7L.S6:=-^(;8I&/ES'@K)6W%I476_A M*AAJ5'4##;DO1BY"PR^YW^`NB.5R:#\]"81XA$&)VGU7CPZ2W%HX'@4$;Z.2 M2R`.TELB2CK6(U95UEJ\O@4\];JZ@44FVB5GH5D+5T5A+99LWLC5*^P&+)\# M4)41\2A'HN#6,]FQ?A(\J1I/YT0Z&FO!9*S5.5H5EV#JAS#PG\=R>'Q*P*8P MYI$6A<\Q4:9E47\J`WS95I@KP6=$I(]R#UI:5$WC;9V]P5H`NUT5Z-JTA0H# MW+*-GA>9N6OT.\JF38Q,I!"JK-7*5JOB)=%4(#V5M0!ZNTJ!,8$;+4.AWV_N M4BL+VPOJML-&H[$;D$#3(:>C229C/1JKY>S%;]L!4:VG&Q@TV=[4YEL>X^-[ M*P=M?4&#$8V79S#6MNHWMTMX#EB\MCSV1^-E:AOG$$4'I'0T6-1<&1,VZ^\& M3OFV_<6IG<8@1UUY+#ZN#,_T>CN#C9C#<'ZM*FGAJ2/!(M3]OH?6".FU=P.D MTSFYX==$S?ZN`H%"24>##N@Z`E.S_F[@=,Y2`J9,L0U=77DL/JX,L?5ZNX&- M.C<*@YL+'C!T3Z0EPJ*TY741-$H("[@!E4EGM$$O=.#*;,GU[J<@G\G*2`,9 M%J4M!^'QV+B^2'*2G3.]($%"!J.83LK)'*J6?VL(L-!L;2*$L_KJRJ]6??.` M]V$6\)XMCA39#WF?DE'://`K%L(BN;4I4QLD*]3\%M"K-(5A\XE'=&M3K#:( M:E5WH_4LB(C"!+_O8FNC]`V1^)9\JTTXMX,`[N'6AI!ML'TI<=NK12U3`JL= M6?J3!.`(O3UB9K;7!J4-\-C*Y)&E!&HH^!8%"!DM)&GS$- MJ:8'P]!BD7-J+H\YRR,YY'*ZR>4J=-4T-$\E4&W&RX-P5D*1@11 M)HOPJ_N6> M83.ST+<0@BAKG)T/[\_36R[H'T\M1%-=6*>S?5:NLTI09Y)O%?P6,8WVZ1*V MMLC<,?SZN?*+Q;\0$C#O#5#$MD_Y;5`/#(SCQNA\+<\'IAW7$EE+[MM]R M"VZ8[*;..&W:[JT%-[M$'1?DM#&C:KC#HC2;>J6;33TQ\OC8*["RN:-0)L1? M"M8\=:HEL!KBO"-LKEM7?2IA><;38.^U,&59,5=ZKP0<_A/G43+DL;;'6BEH M>ZIA9OT:/=T`09W.OA)\K(O?EPK9'NB;&;]"/S<,GS?;;/+Q8488=!>(\Z;U M)+;';6:@-.KN!D3%`^PKY]9UV]HT1+8'6LV&7SN3VF0!-Z`:$K6(`C)^#L17 M4E!1$[W5T-A.O&$*5+/^;N"474(9R[H432E3UV^D](XT@M5(:#M/ABEB2$NX M`=N:<@:=E/UL%:;0U&KK&!A9IWNAS2Y46=AZCHK6B*RK[`@F,HM&)IS,;X(? MTC70VK&\`!N;?)D&(Q85]"-=O&2 MI)@1WDHQZ\E'S*Q?J:0;]O^5T,DM^&#_#EKH";F<3T=$#,;9,I.Z&RGZ$"0T MK(<&S\%ZI@LSU$Q-XP:@BUW:B\5\)2(T\:Z)?-&0NN),,S@0QK"M773 MP5BFRSZ+^7W-JNEKU*JI7#25C+R,DQ.;3Y>*&6TZK:"RVU])@:X$OZ.`\(?' MGQ,2G;/E#+(?IO0NVSG=J&0;7NYL0JU%<[WS:VDQ-QK4[8Y0M@74!E9_,6.7 M?O2_>9*J/2+R:`.H>PZ5,Y'9J4+XF\:D)/P-[\QSM_]FVPO0+1S]N>!PH_(5 M5PUQ"Z7VMXT^&T+U"ZQN@5AQ"QZP@:`3RM079X0DVC3F9EQL[V*P M5`G:F-J-2K*8/9!(;6^"*038C4QG,7\D9$C$'0U).YC5I?F2-'H2V]LQ MGAO=9HNXU`J`XD)F,SLEV6]05<94G_3-$MBQ8OY:L!=JD_!FC&UO"FDQ5.S( MF$[7C$46\(9;!7#4MG>7=`48JAI46LY5K%?RBIL`O4:*1'EKV>2>"^4:FSD, M\4IB./#HEV$[1W8 MVK8=Y,W-Z#3\Y^R.)!VMWFAY6=_#]:S5`6%6-ZH%C$/4M/>&]\/?YU20%I=A MFO"POOMK`\!X:ZV=0ESPD)`H.0/+#(.8#,9M(#=A8GW#6'>8F]ONY>\0Q%NO MBQ[#@>O/.JLNYI9SHXFHD3O/W=#)6$'+R_KU7<\Z5D"8U8UJ46S]U"4^C8&? M>@KK&R(W`*.^3ZBRBGO879-9/G89C,UQK*>VODMR*Y@V60&K/EJY$#(D%+^AYIN9,F3Y`TUT!?-IR3J:;I@$R;6+RWK#.H6 MMG,#]&*+DTLHA:T'N)8`"^;6@BZ=@=E@$S>`6Q\VKMQ(J=U+A:/&0OK<`11S M2$VLY0:^JH/(CK^"NP^[Z76/+N8&X%!JF]/*7C.+=!;'L;K+*NMI6U6-NQL7Z+7J=H=[&>B[C MW@>["/$()E`-E2G@:^3H#?`O%.D:>VV8DG>8PMC=?@C\.:K(EP,'KG)\WDHB M5>ZDFCB1N7DXG\UBM1LTB!>[0<_9F(MI@+QN!,O`^JV0W8T-S6SF1H?Q-$VA MFD/EY5+6[X0TM71U^I.BRJZ`(7?EWP0/,C"KQV.EH/4['S>%I%+QYSSR<<;% MX@Q*A=UK#SF4R*S?Z-@2!9QV+GF*;AY^PMD=$8DZH)9]3NDH)D,20LE\=7,P M+AR3:1?B:/$:Z_=&;N:E6S&Z(_7)\&P:-%4?""/:3.2;\+1^J>2&-65C5>J>P@A+H\,Z9A,1I4ROGRQO.]4YJ$ M,4^`'_PAV7L]^4&]069[>7J'%[#(*[S%>WJ-MWR/Q4/7:THC$BYH:"QZO\PI M)-=BRM(]9C]OH-I\B+6KSEAZRUE?FA%;<6,SNSCDL@?^XF2Z/(I>[8QO*YWQ M0#[-:3U%_*>'=9)F(S/I"70,$QCD8SVKB>ZE>13.#@YYTJ%?N4^HY$GO*CWI M,/^0>`MBF]5OE#Y)V.Q%=>6M>E!1))3KU!!8]AD]%FO^HM7:(4=YY6LNV"ZY MRU&ENV2WJ#UQ^(>7\["8@U()T.PMJ^5LQP5*&$CC&OF-`0O+GE2-3]6DW<0B M#OG4:_]C/F?,9X?R9$KU<*ZW7^E5,LOF@H>7,_$R+C8ODYO*S#:+FXJN24J% MFFJ;=%%&3.S>`5J4LPI0A%.:<;'LERWP7;\IU-AH#OGM&[\0T*]VUUZEN\H` M24;J9;06>Y+PED1S>2PN.^*D@I:(=4\]F45'/".1O+UAB8PT.,+S&LAL)[+% MH+3B7"A#..1-;WVY(D-SW5ATPM6,D[#:0&/OH-*[WJHTTTM6*KY89F:UFZA3 MT;!7-&%C^6[L1DEQ/:,1'_M]HSG.%?=HFYO.(8]^YW_B(#)('A(A._BUF\2K MW?JPTJUE^$7Q\W*&RK&7++TE3XL7LXA)P/*LH4^)[K/!S57!P(4[U9\N#D?< M3-8->XNMP06%J5D$DS,CW]=36?;T3C%?:0$PYG+(WX_\:Q*2TCJAX`P^AJ2\ M%E[R]E>5WBZC1QFWTGI@F=^?GNZLIU^2^[IJ8+CJ:,[I&VX1VIK5H5:BM^_+ MA+P#!NX=S&@:Q*O75Y>:A]?5FPED'$RR\3CSUAA97&*?)Y21)(&QVRC/$HYP M=SV5S1T#N6"%,U]R6^E$*!FO828JYF&J-DE!Y58)-_)\>B<\23$1K^[>8-GK M,' M"T6Z))4X_?4[ZL6R'$5UT@0#YAJ!(9%WS]T]1XHG7W;?S$).;D!I)L5>S:LW M:@2$+P,F)GNU=T-G?]CM]VODS>N??B3XV?W9<4B/`0\ZY%#Z3E^,Y2MR2D/H MD&,0H*B1ZA5Y3WED1V2/<5"D*\,I!P,XD5CJD%9]BQ+'60'V/8A`JG?G_3GL ME3'3CNO>WM[6A;RAMU)=Z[HO5X,;RDCY,,=ZVSWND\N#\Q/B-?XB^U/%.&DV MO%9]-L8X#JE!&7O_2_.PT<:OYL9%T^MX[G;S-W?''\6?_]P= MW;@GXB`=)/)@B@K%=U*1%DF&L!JQ;#KAVN7B-#RGY64J=I'- MY46D-&@N(S$!7+5A+(]_*`T<0A"F)U5X"&,:<0SR M4A]60,P6&!5"XCK$G9>.V+'IE.%"PX$?=FU&.DIRN+B;`K$7N-\>QK<"+J[4 MR'J[+X(C89BYL\M6A;&5&F'!7JU2PMI%+V++`8R98+%[Z>;`S44R]<5+*@*2 M8)$%L%UW&68!/-(0#,3K^'JJ0"-,K'2"`ZEB*O*`DD^Y'_''Z>2NE*JD`QGC M3\[!`>5V8PRO`(Q.2"\.5;/<1&KM\PE2FKM2:,E9@",!28%(@O2=8LO"&548 MVQ48AAZ7\%V9W^@?C+M57/2YOE\E?G*FF?G,EZBWS%I'$D&O+_*DTX#FG6$HJ&(SW M?<-NT"AH/%J';"*P0/`I'K2^CWH&:_ M6#O$'MV)*9N[W%A\=B^8([D]DAEK"8N:7QZIQLE^;$'O09 M"+$H:TUTR['?>%C?T1&'G.BE\6JB=TJ);J47FJ0H:TWTAC,TTK^^DCS`]_ZC MSQ'6[3G=I;/5I+=+24\.\1SJ5Y*`K37WF\Y1..7R#N``!)HU9UA1+CQ5'IBO MY-]KE/)O3_(,C*1H)(9;ZPQL.7V!`W!!9XN/\^)P-=]>*=_VW$TP2`RRUBQO M.UT9ALS$=3H6-%A&VI("1+'\J1:KSD*S-`O;<3--\_25R6K<[11FB-[H">PA=>!`O!:Y\=K."=2ZX%`ENB4&?69#G)/'^-$3L/CG,CTGN!$C*;!KT_D#2:5 M%7J6#WA1JF,OG%QY5?N5/=,J^Z6*+G"CLY%O],9N'OU,[L183_"GD._`*-<" MN4(*1T0A*.:OME(6-4\31;M4VG:I>%O?Z,S3'/F:%VD#/"YM;-/\4U4+>7^D MC:*^J<5>5[>;$6Y_S[$73=9 MZWCY+U!+`0(>`Q0````(`#2+.$.MH4CK&R\``"7+`0`1`!@```````$```"D M@0````!M8V=I+3(P,3,P,3,Q+GAM;%54!0`#4P-"4G5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`#2+.$-,",6Z(@4``*L>```5`!@```````$```"D@68O M``!M8V=I+3(P,3,P,3,Q7V-A;"YX;6Q55`4``U,#0E)U>`L``00E#@``!#D! M``!02P$"'@,4````"``TBSA#5G';QZP$``!$'```%0`8```````!````I('7 M-```;6-G:2TR,#$S,#$S,5]D968N>&UL550%``-3`T)2=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`-(LX0Y);'B#2&0``(5`Q0````(`#2+.$/=8T#&FA$``.GN```5`!@```````$```"D M@?-3``!M8V=I+3(P,3,P,3,Q7W!R92YX;6Q55`4``U,#0E)U>`L``00E#@`` M!#D!``!02P$"'@,4````"``TBSA#(L*]O24&```V)0``$0`8```````!```` MI('<90``;6-G:2TR,#$S,#$S,2YX`L``00E#@``!#D! 8``!02P4&``````8`!@`:`@``3&P````` ` end XML 44 R1.xml IDEA: Document and Entity Information 2.4.0.800000001 - Document - Document and Entity Informationtruefalsefalse1false falsefalseFrom2013-02-01to2013-04-30http://www.sec.gov/CIK0001438901duration2013-02-01T00:00:002013-04-30T00:00:002false USDfalsefalse$AsOf2013-09-05http://www.sec.gov/CIK0001438901instant2013-09-05T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1MCGI_DocumentAndEntityInformationAbstractMCGI_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Document And Entity Information2false 2dei_EntityRegistrantNamedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00MEDCAREERS GROUP, Inc.falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false0Entity Registrant Name3false 2dei_EntityCentralIndexKeydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse000001438901falsefalsefalse2falsefalsefalse00falsefalsefalsedei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false0Entity Central Index Key4false 2dei_DocumentTypedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0010-Qfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:submissionTypeItemTypestringThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".No definition available.false0Document Type5false 2dei_DocumentPeriodEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013-01-31falsefalsetrue2falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No definition available.false0Document Period End Date6false 2dei_AmendmentFlagdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:booleanItemTypenaIf the value is true, then the document is an amendment to previously-filed/accepted document.No definition available.false0Amendment Flag7false 2dei_CurrentFiscalYearEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00--01-31falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No definition available.false0Current Fiscal Year End Date8false 2dei_EntityWellKnownSeasonedIssuerdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.No definition available.false0Is Entity a Well-known Seasoned Issuer?9false 2dei_EntityVoluntaryFilersdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.No definition available.false0Is Entity a Voluntary Filer?10false 2dei_EntityCurrentReportingStatusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Nofalsefalsefalse2falsefalsefalse00falsefalsefalsedei:yesNoItemTypenaIndicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false0Is Entity's Reporting Status Current?11false 2dei_EntityFilerCategorydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Smaller Reporting Companyfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:filerCategoryItemTypestringIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false0Entity Filer Category12false 2dei_EntityPublicFloatdei_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse5270886352708863USD$falsetruefalsexbrli:monetaryItemTypemonetaryState aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.No definition available.false2Entity Public Float13false 2dei_EntityCommonStockSharesOutstandingdei_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse5270886352708863falsefalsefalsexbrli:sharesItemTypesharesIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.No definition available.false1Entity Common Stock, Shares Outstanding14false 2dei_DocumentFiscalPeriodFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Q1falsefalsefalse2falsefalsefalse00falsefalsefalsedei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No definition available.false0Document Fiscal Period Focus15false 2dei_DocumentFiscalYearFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002013falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No definition available.false0Document Fiscal Year FocusfalseDocument and Entity Information (USD $)NoRoundingNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://nurseslounge.com/role/DocumentAndEntityInformation215